<SEC-DOCUMENT>0001104659-23-073116.txt : 20230621
<SEC-HEADER>0001104659-23-073116.hdr.sgml : 20230621
<ACCEPTANCE-DATETIME>20230621070021
ACCESSION NUMBER:		0001104659-23-073116
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20230615
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230621
DATE AS OF CHANGE:		20230621

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Verastem, Inc.
		CENTRAL INDEX KEY:			0001526119
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				273269467
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35403
		FILM NUMBER:		231027381

	BUSINESS ADDRESS:	
		STREET 1:		117 KENDRICK STREET
		STREET 2:		SUITE 500
		CITY:			NEEDHAM
		STATE:			MA
		ZIP:			02494
		BUSINESS PHONE:		(781) 292-4200

	MAIL ADDRESS:	
		STREET 1:		117 KENDRICK STREET
		STREET 2:		SUITE 500
		CITY:			NEEDHAM
		STATE:			MA
		ZIP:			02494
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2318315d3_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:srt-supplement="http://fasb.org/srt-sup/2022q3" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:vstm="http://verastem.com/20230615">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_037_vstm_verastem.com_20230615 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20230615_20230615 -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0001526119 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 5pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityCentralIndexKey">0001526119</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="vstm-20230615.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-06-15to2023-06-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001526119</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-15</xbrli:startDate>
        <xbrli:endDate>2023-06-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0; font-size: 10pt">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0; font-size: 10pt">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_90F_edei--DocumentType_c20230615__20230615_zQEyUHGDMCH"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:DocumentType">8-K</ix:nonNumeric></span></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):
<b><span id="xdx_903_edei--DocumentPeriodEndDate_c20230615__20230615_zc1LGzLjELa"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 15, 2023</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--EntityRegistrantName_c20230615__20230615_zwScYmMZqsK5"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityRegistrantName">Verastem, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span>&#160;</span></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in
Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="padding: 0.25pt; vertical-align: top; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20230615__20230615_z0gPp9MmOBD2"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="padding: 0.25pt; text-align: center; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: top; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90A_edei--EntityFileNumber_c20230615__20230615_zfRAbESsfaE7"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityFileNumber">001-35403</ix:nonNumeric></span></b></span></td>
    <td style="padding: 0.25pt; text-align: center; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: top; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20230615__20230615_zgHKxipB3UPl"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityTaxIdentificationNumber">27-3269467</ix:nonNumeric></span></b></span></td></tr>
<tr>
    <td style="padding: 0.25pt; text-align: center; vertical-align: top">(State or Other Jurisdiction <br />
of Incorporation)</td>
    <td style="padding: 0.25pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(Commission<br /> File Number)</span></td>
    <td style="padding: 0.25pt; text-align: center; vertical-align: bottom">&#160;</td>
    <td style="padding: 0.25pt; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif">(IRS Employer<br /> Identification No.)</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 49%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90E_edei--EntityAddressAddressLine1_c20230615__20230615_zlfOLB7WYh8c"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityAddressAddressLine1">117 Kendrick Street</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressAddressLine2_c20230615__20230615_z5Sw9dwHMpRi"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityAddressAddressLine2">Suite 500</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressCityOrTown_c20230615__20230615_z9h8HPXjLJWf"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityAddressCityOrTown">Needham</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressStateOrProvince_c20230615__20230615_zCEp0b65Y1Ji"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityAddressStateOrProvince">MA</ix:nonNumeric></span></b></span></td>
    <td style="text-align: center; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; width: 49%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_905_edei--EntityAddressPostalZipCode_c20230615__20230615_zmSS8o3bhy2f"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:EntityAddressPostalZipCode">02494</ix:nonNumeric></span></b></span></td></tr>

<tr>
    <td style="vertical-align: top; text-align: center; width: 49%"><span style="font: 10pt Times New Roman, Times, Serif">(Address of Principal Executive Offices)</span></td>
    <td style="text-align: center; vertical-align: bottom; width: 2%">&#160;</td>
    <td style="vertical-align: top; text-align: center; width: 49%"><span style="font: 10pt Times New Roman, Times, Serif">(Zip Code)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s telephone number, including
area code: <b>(<span id="xdx_900_edei--CityAreaCode_c20230615__20230615_zed7w675Q7zc"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:CityAreaCode">781</ix:nonNumeric></span>) <span id="xdx_904_edei--LocalPhoneNumber_c20230615__20230615_zBC6wcIHr6Vj"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:LocalPhoneNumber">292-4200</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address, if Changed
Since Last Report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_905_edei--WrittenCommunications_c20230615__20230615_ziOzabFRSF12"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Written communications pursuant to Rule&#160;425&#160;under
the&#160;Securities Act&#160;(17 CFR 230.425)</td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td style="text-align: left"><span style="font-family: Wingdings"><span id="xdx_901_edei--SolicitingMaterial_c20230615__20230615_zGQd6ABmR7ej"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Soliciting material pursuant to Rule&#160;14a-12&#160;under
the&#160;Exchange Act&#160;(17 CFR 240.14a-12)</td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td style="text-align: left"><span style="font-family: Wingdings"><span id="xdx_907_edei--PreCommencementTenderOffer_c20230615__20230615_z12EluyThWV1"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under
the&#160;Exchange Act&#160;(17 CFR 240.14d-2(b))</td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td style="text-align: left"><span style="font-family: Wingdings"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20230615__20230615_zeUkftfFUnK5"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under
the&#160;Exchange Act&#160;(17 CFR 240.13e-4(c))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #221e1f">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Title of each class</b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Trading<br />Symbol(s)</b></span></td>
    <td style="text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center; width: 32%"><span style="font: 10pt Times New Roman, Times, Serif"><b>Name
    of each exchange on which registered</b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--Security12bTitle_c20230615__20230615_zSiqTdr4HcV6"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:Security12bTitle">Common stock, $0.0001 par value per share</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--TradingSymbol_c20230615__20230615_zev0xk07Jos"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" name="dei:TradingSymbol">VSTM</ix:nonNumeric></span></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">The <span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_edei--SecurityExchangeName_c20230615__20230615_zmZ8gPE40dQc"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Emerging
growth company </span><span style="font-family: Wingdings"><span style="font-family: Wingdings"><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20230615__20230615_zAjWw3c4QiY1"><ix:nonNumeric contextRef="From2023-06-15to2023-06-15" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Item 8.01 Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">On June&#160;15, 2023, Verastem,&#160;Inc.
(the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with RBC Capital Markets,
LLC and Cantor Fitzgerald&#160;&amp; Co., as representatives of the several underwriters named in Schedule I thereto (the &#8220;Underwriters&#8221;),
relating to the underwritten offering of 7,181,409 shares (the &#8220;Firm Shares&#8221;) of the Company&#8217;s common stock, par value
$0.0001 per share (the &#8220;Common Stock&#8221;), at a price to the public of $9.75 per Share, less the underwriting discounts and commissions,
and, in lieu of Common Stock to certain investors, pre-funded warrants to purchase up to an aggregate of 1,538,591 shares of Common Stock
at a price to the public of $9.749 (the &#8220;Pre-Funded Warrants&#8221;) per Pre-Funded Warrant, which represents the per share public
offering price for the Shares less the $0.001 per share exercise price for each such Pre-Funded Warrant (the &#8220;Offering&#8221;).
In addition, the Company granted the Underwriters an option to purchase, at the public offering price less any underwriting discounts
and commissions, an additional 1,308,000 shares of Common Stock (such additional shares, together with the Firm Shares, the &#8220;Shares&#8221;),
exercisable for 30 days from the date of the Underwriting Agreement, which the Underwriters exercised in full on June&#160;16, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Each Pre-Funded Warrant will have an exercise
price equal to $0.001 per share of Common Stock. The exercise price and the number of shares of Common Stock issuable upon exercise of
each Pre-Funded Warrant is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits,
stock combinations, reclassifications or similar events affecting the Common Stock as well as upon any distribution of assets, including
cash, stock or other property, to the Company&#8217;s stockholders. The Pre-Funded Warrants will not expire and are exercisable in cash
or by means of a cashless exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The Company may not effect the exercise of
any Pre-Funded Warrant, and a holder will not be entitled to exercise any portion of any Pre-Funded Warrant if, upon giving effect to
such exercise, the aggregate number of shares of Common Stock beneficially owned by the holder (together with its affiliates) would exceed
9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the exercise, which percentage may be increased
or decreased at the holder&#8217;s election upon 61 days&#8217; notice to the Company subject to the terms of such Pre-Funded Warrants,
provided that such percentage may in no event exceed 19.99%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">In addition, upon the consummation of an acquisition
(as described in the Pre-Funded Warrants), each Pre-Funded Warrant will automatically be converted into the right of the holder of such
Pre-Funded Warrant to receive the kind and amount of securities, cash or other property that such holders would have received had they
exercised such Pre-Funded Warrant immediately prior to such acquisition, without regard to any limitations on exercise contained in the
Pre-Funded Warrants. The foregoing description of the Pre-Funded Warrants is qualified in its entirety by reference to the Form&#160;of
Warrant filed as Exhibit&#160;4.1 to this Current Report on Form&#160;8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The Offering was made pursuant to the Company&#8217;s
shelf registration statement on Form&#160;S-3 (File No.&#160;333-258372), which was declared effective on April&#160;6, 2022. The closing
of the Offering is expected to take place on or about June&#160;21, 2023, subject to the satisfaction of customary closing conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The Underwriting Agreement contains customary
representations, warranties, and agreements by the Company and customary conditions to closing, indemnification obligations of the Company
and the Underwriters, including for liabilities under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and termination
provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">A copy of the Underwriting Agreement and the
form of Pre-Funded Warrant are filed as Exhibits 1.1 and 4.1, respectively, to this Current Report on Form&#160;8-K and are incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Ropes&#160;&amp; Gray, LLP, counsel to the
Company, has issued an opinion to the Company, dated June&#160;21, 2023, regarding the Shares and Pre-Funded Warrants to be sold in the
Offering. A copy of the opinion is filed as Exhibit&#160;5.1 to this Current Report on Form&#160;8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">This Current Report on Form&#160;8-K, including
the exhibits hereto, shall not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company, which
is being made only by means of a written prospectus meeting the requirements of Section&#160;10 of the Securities Act, nor shall there
be any sale of the Company&#8217;s securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of such jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="background-color: white"><b>Item
9.01. Financial Statements and Exhibits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm2318315d3_ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2318315d3_ex1-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Underwriting Agreement, dated June&#160;15, 2023, among Verastem,&#160;Inc. and RBC Capital Markets, LLC and Cantor Fitzgerald&#160;&amp; Co., as representatives of the several underwriters</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm2318315d3_ex4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2318315d3_ex4-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Pre-Funded Warrant</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm2318315d3_ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2318315d3_ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Ropes&#160;&amp; Gray LLP</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm2318315d3_ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2318315d3_ex5-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Ropes&#160;&amp; Gray LLP (included in Exhibit&#160;5.1 above)</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><a href="tm2318315d3_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="tm2318315d3_ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information relating to Item 14 of the Registration Statement</span></a></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VERASTEM,&#160;INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 46%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: June&#160;21, 2023</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Brian M. Stuglik</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian M. Stuglik</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chief Executive Officer</i></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6PbTOH2R3OlTEKTKGeFtcJsWtGWn9eyTf0m5DDIGQnPPlCBGKDa11hQznZZZCjnVTKYeQYYmM5oLekWx3MfiZ4VVbx8q4bv2BCXkGPTMdjC/+3jkf2mIRg5wN5WQYSZDzeDKFxV4ErZ6QKXWBxmlVgTIFHJka1ugUv/sPuXqRofrdJZ2QrSYTw2gge/kDkRxFcKCHehLfLKRpIoKwq0BsmO5NG3O3jmpYVVj7LNuj/w6+2CJJDw== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>tm2318315d3_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 1.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Verastem,&nbsp;Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">7,181,409 Shares of Common Stock<BR>
Pre-Funded Warrants to Purchase 1,538,591 Shares of Common Stock<BR>
($0.0001&nbsp;par value per share)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Underwriting Agreement</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-align: right">New York, New York<BR>
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;June&nbsp;15, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RBC Capital Markets, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cantor Fitzgerald&nbsp;&amp; Co.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As Representatives of the several Underwriters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">listed on Schedule I hereto</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o RBC Capital Markets, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brookfield Place<BR>
200 Vesey Street<BR>
New York, New York 10281-8098</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o Cantor Fitzgerald&nbsp;&amp; Co.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">499 Park Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Verastem,&nbsp;Inc., a Delaware
corporation (the &ldquo;<U>Company</U>&rdquo;), proposes to sell to the several underwriters named in Schedule I hereto (the &ldquo;<U>Underwriters</U>&rdquo;),
for whom you (the &ldquo;<U>Representatives</U>&rdquo;) are acting as representatives, (i)&nbsp;7,181,409 shares (the &ldquo;<U>Underwritten
Shares</U>&rdquo;) of common stock, $0.0001 par value per share (&ldquo;<U>Common Stock</U>&rdquo;) of the Company and (ii)&nbsp;pre-funded
warrants to purchase an aggregate of 1,538,591 shares of Common Stock at an exercise price equal to $0.001 per share (the &ldquo;<U>Pre-Funded
Warrants</U>&rdquo; and, together with the Underwritten Shares, the &ldquo;<U>Underwritten Securities</U>&rdquo;). The Company also proposes
to grant to the Underwriters an option to purchase up to 1,308,000 additional shares of Common Stock (the &ldquo;<U>Option Securities</U>&rdquo;;
the Option Securities, together with the Underwritten Shares, being hereinafter called the &ldquo;<U>Shares</U>&rdquo;). The Underwritten
Securities and any Option Securities purchased pursuant to this underwriting agreement (this &ldquo;<U>Agreement</U>&rdquo;) are herein
collectively called the &ldquo;<U>Securities</U>.&rdquo; The shares of Common Stock issuable upon exercise of the Pre-Funded Warrants
are herein collectively called the &ldquo;<U>Warrant Shares</U>.&rdquo; To the extent there are no additional Underwriters listed on Schedule
I other than you, the term Representatives as used herein shall mean you, as Underwriters, and the terms Representatives and Underwriters
shall mean either the singular or plural as the context requires.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">1.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Representations
and Warranties of the Company.</U> The Company hereby represents and warrants to, and agrees with, each Underwriter, as of the date of
this Agreement, as of the Closing Date (as defined herein), and as of each additional Settlement Date (as defined herein), if any, as
set forth below in this Section&nbsp;1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has prepared and filed with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) under the Securities
Act of 1933, as amended, and the rules&nbsp;and regulations of the Commission thereunder (the &ldquo;<U>Act</U>&rdquo;), a shelf registration
statement (file number 333-258372) on Form&nbsp;S-3, as amended by Post-Effective Amendments No.&nbsp;1 and No.&nbsp;2 thereto, not earlier
than three years prior to the date hereof and such registration statement became effective upon filing as of the Effective Date (as defined
herein) under the Act by the Commission. Such registration statement, as of any time, means such registration statement as amended by
any post-effective amendments thereto at such time, including the exhibits and any schedules thereto at such time, the documents incorporated
by reference therein at such time pursuant to Item 12 of Form&nbsp;S-3 under the Act and the documents otherwise deemed to be a part thereof
as of such time pursuant to Rule&nbsp;430B (&ldquo;<U>Rule&nbsp;430B</U>&rdquo;) under the Act (the &ldquo;<U>Rule&nbsp;430B Information</U>&rdquo;),
is referred to herein as the &ldquo;<U>Registration Statement</U>;&rdquo; provided, however, that the &ldquo;Registration Statement&rdquo;
without reference to a time means such registration statement as amended by any post-effective amendments thereto as of the time of the
first contract of sale for the Securities, which time shall be considered the &ldquo;new effective date&rdquo; of such registration statement
with respect to the Securities within the meaning of paragraph (f)(2)&nbsp;of Rule&nbsp;430B of the Act, including the exhibits and schedules
thereto as of such time, the documents incorporated or deemed incorporated by reference therein at such time pursuant to Item 12 of Form&nbsp;S-3
under the Act and the Rule&nbsp;430B Information. Any registration statement filed pursuant to Rule&nbsp;462(b)&nbsp;of the Act is hereinafter
called the &ldquo;<U>Rule&nbsp;462(b)&nbsp;Registration Statement</U>,&rdquo; and after such filing the term &ldquo;Registration Statement&rdquo;
shall include the 462(b)&nbsp;Registration Statement. The base prospectus in the form in which it has most recently been filed with the
Commission on or prior to the date of this Agreement is herein called the &ldquo;Base Prospectus<I>.</I>&rdquo; Each preliminary prospectus
supplement to the Base Prospectus (including the Base Prospectus as so supplemented), that describes the Securities and the offering thereof,
that omitted the Rule&nbsp;430B Information and that was used prior to the filing of the final prospectus supplement referred to in the
following sentence is herein called a &ldquo;<U>Preliminary Prospectus</U><I>.</I>&rdquo; Promptly after execution and delivery of this
Agreement, the Company will prepare and file with the Commission a final prospectus supplement to the Base Prospectus relating to the
Securities and the offering thereof in accordance with the provisions of Rule&nbsp;430B and Rule&nbsp;424(b)&nbsp;of the Act. Such final
prospectus supplement (including the Base Prospectus as so supplemented) in the form filed with the Commission pursuant to Rule&nbsp;424(b)&nbsp;is
herein called the &ldquo;<U>Prospectus</U>.&rdquo; Any reference herein to the Base Prospectus, any Preliminary Prospectus or the Prospectus
shall be deemed to refer to include the documents incorporated by reference therein pursuant to Item 12 of Form&nbsp;S-3 under the Act
as of the date of such prospectus.&nbsp;&ldquo;<U>Effective Date</U>&rdquo; shall mean each date and time that the Registration Statement,
any post-effective amendment or amendments thereto and any Rule&nbsp;462(b)&nbsp;Registration Statement became or becomes effective (including
each deemed effective date with respect to the Underwriters pursuant to Rule&nbsp;430B or otherwise under the Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of this Agreement,
all references to the Registration Statement, the Rule&nbsp;462(b)&nbsp;Registration Statement, the Base Prospectus, any Preliminary Prospectus,
the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant
to its Electronic Data Gathering, Analysis and Retrieval System or any successor system thereto <B>(</B>&ldquo;<U>EDGAR</U>&rdquo;). All
references in this Agreement to financial statements and schedules and other information which is &ldquo;described,&rdquo; &ldquo;contained,&rdquo;
 &ldquo;included&rdquo; or &ldquo;stated&rdquo; in the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Prospectus
(or other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information
which is incorporated by reference in or otherwise deemed by the Act to be a part of or included in the Registration Statement, the Base
Prospectus, any Preliminary Prospectus or the Prospectus, as the case may be; and all references in this Agreement to amendments or supplements
to the Registration Statement, the Base Prospectus, any Preliminary Prospectus or the Prospectus shall be deemed to mean and include the
subsequent filing of any document under the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations thereunder
(the &ldquo;<U>Exchange Act</U>&rdquo;), and which is deemed to be incorporated by reference therein or otherwise deemed by the Exchange
Act to be a part thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The term &ldquo;<U>Disclosure
Package</U>&rdquo; means (i)&nbsp;the Preliminary Prospectus, as most recently amended or supplemented immediately prior to 8:00 p.m.&nbsp;New
York City time, on June&nbsp;15, 2023 (the &ldquo;<U>Execution Time</U>&rdquo;), (ii)&nbsp;any issuer free writing prospectus, as defined
by Rule&nbsp;433 of the Act (an &ldquo;<U>Issuer Free Writing Prospectus</U>&rdquo;) identified in <U>Schedule&nbsp;II</U> hereto, (iii)&nbsp;any
other free writing prospectus, as defined by Rule&nbsp;405 (a &ldquo;<U>Free Writing Prospectus</U>&rdquo;) that the parties hereto shall
hereafter expressly agree to treat as part of the Disclosure Package and (iv)&nbsp;the information set forth on <U>Schedule&nbsp;III</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Preliminary Prospectus when filed and the Registration Statement as of the Effective Date and as of the Execution Time, complied or will
comply, and the Prospectus and any further amendments or supplements to the Registration Statement, the Preliminary Prospectus or the
Prospectus will, when they become effective or are filed with the Commission, as the case may be, comply, in all material respects with
the requirements of the Act; the documents incorporated by reference in the Registration Statement and the Prospectus, when they became
effective or at the time they were or hereafter are filed with the Commission, complied and will comply in all material respects with
the requirements of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
of the Effective Date, the Registration Statement did not and will not contain any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary in order to make the statements therein not misleading. As of the Execution
Time, the Closing Date (as defined in Section&nbsp;2 herein) and on any date on which Option Securities are purchased, if such date is
not the Closing Date (a &ldquo;<U>Settlement Date</U>,&rdquo;), the Disclosure Package does not, and the Prospectus (together with any
supplement thereto) will not, include any untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U>, <U>however</U>,
that the Company makes no representations or warranties as to the information contained in or omitted from the Registration Statement
or the Prospectus (or any supplement thereto) in reliance upon and in conformity with information furnished in writing to the Company
by or on behalf of any Underwriter through the Representatives specifically for inclusion in the Registration Statement or the Prospectus
(or any supplement thereto), it being understood and agreed that the only such information furnished by any Underwriter consists of the
information described as such in Section&nbsp;7 hereof. There are no contracts or other documents required to be described in the Disclosure
Package or the Prospectus or filed as an exhibit to the Registration Statement which have not been described or filed as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
of the Execution Time, the Closing Date and the Settlement Date, as applicable, (i)&nbsp;the Disclosure Package, and (ii)&nbsp;each electronic
roadshow when taken together as a whole with the Disclosure Package, did not, does not, and will not, contain any untrue statement of
a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. The preceding sentence does not apply to statements in or omissions from the Disclosure Package
or any electronic roadshow based upon and in conformity with written information furnished to the Company by any Underwriter through the
Representatives specifically for use therein, it being understood and agreed that the only such information furnished by or on behalf
of any Underwriter consists of the information described as such in Section&nbsp;7 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has complied to the Commission&rsquo;s satisfaction with all requests of the Commission for additional or supplemental information.
The Company satisfies all requirements of the Act for use of Form&nbsp;S-3. No stop order suspending the effectiveness of the Registration
Statement has been issued and, to the knowledge of the Company, no proceeding for that purpose has been instituted or threatened by the
Commission. No order preventing or suspending the use of the Prospectus has been issued and, to the knowledge of the Company, no proceeding
for that purpose has been instituted by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(i)&nbsp;At
the Effective Date and (ii)&nbsp;as of the Execution Time (with such date being used as the determination date for purposes of this clause
(ii)), the Company was not and is not an Ineligible Issuer (as defined in Rule&nbsp;405), without taking account of any determination
by the Commission pursuant to Rule&nbsp;405 that it is not necessary that the Company be considered an Ineligible Issuer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company is eligible to use Free Writing Prospectuses in connection with this offering pursuant to Rules&nbsp;164 and 433 under the Act;
any Free Writing Prospectuses that the Company is required to file pursuant to Rule&nbsp;433(d)&nbsp;under the Act has been, or will be,
filed with the Commission in accordance with the requirements of the Act; and each Free Writing Prospectus that the Company has filed,
or is required to file, pursuant to Rule&nbsp;433(d)&nbsp;under the Act or that was prepared by or on behalf of or used by the Company
complies or will comply in all material respects with the requirements of the Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
Issuer Free Writing Prospectus does not include any information that conflicts with the information contained in the Registration Statement,
including any document incorporated by reference therein that has not been superseded or modified. The foregoing sentence does not apply
to statements in or omissions from any Issuer Free Writing Prospectus based upon and in conformity with written information furnished
to the Company by any Underwriter through the Representatives specifically for use therein, it being understood and agreed that the only
such information furnished by or on behalf of any Underwriter consists of the information described as such in Section&nbsp;7 hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
copies of each Preliminary Prospectus, each Issuer Free Writing Prospectus that is required to be filed with the Commission pursuant to
Rule&nbsp;433 and the Prospectus and any amendments or supplements to any of the foregoing, that have been delivered to the Underwriters
in connection with the offering of the Securities (whether to meet the request of purchasers pursuant to Rule&nbsp;173(d)&nbsp;or otherwise)
were identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted
by Regulation S-T. For purposes of this Agreement, references to the &ldquo;delivery&rdquo; or &ldquo;furnishing&rdquo; of any of the
foregoing documents to the Underwriters, and any similar terms, include, without limitation, electronic delivery.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
documents filed by the Company pursuant to Sections 12, 13, 14 or 15 of the Exchange Act and incorporated or deemed to be incorporated
by reference into the Registration Statement, any Preliminary Prospectus, the Disclosure Package or the Prospectus, when they became effective
or were filed with the Commission, as the case may be, complied in all material respects with the requirements of the Act or the Exchange
Act, as applicable and were filed on a timely basis with the Commission, and none of such documents contained an untrue statement of a
material fact or omitted to state a material fact necessary to make the statements therein, in the light of the circumstances under which
they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
of the Company and its significant subsidiaries (as such term is defined in Rule&nbsp;1-02 of Regulation S-X promulgated by the Commission)
(the &ldquo;Subsidiaries&rdquo;) has been duly organized and is validly existing and in good standing as a corporation or other business
entity under the laws of the jurisdiction in which it is chartered or organized with full corporate, limited liability company or limited
partnership power and authority to own or lease, as the case may be, and to operate its properties and conduct its business as described
in the Registration Statement, the Disclosure Package and the Prospectus, and is duly qualified to do business as a foreign corporation
and is in good standing under the laws of each jurisdiction which requires such qualification, except where the failure to be so qualified
or in good standing or have such power or authority would not, individually or in the aggregate, have a material adverse effect on or
affecting the assets, business, operations, earnings, properties, condition (financial or otherwise), prospects, stockholders&rsquo; equity
or results of operations of the Company and the Subsidiaries taken as a whole, or prevent or materially interfere with the consummation
of the transactions contemplated hereby (a &ldquo;<U>Material Adverse Effect</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
the outstanding shares of capital stock or limited liability company or limited partnership interests, as applicable, of each Subsidiary
have been duly and validly authorized and issued and are fully paid and nonassessable, and, except as otherwise set forth in the Registration
Statement, the Disclosure Package and the Prospectus, all outstanding shares of capital stock or interests of the Subsidiaries are owned
by the Company either directly or through wholly owned Subsidiaries free and clear of any perfected security interest or any other security
interests, claims, liens or encumbrances. Except as set forth in the Registration Statement, the Disclosure Package and the Prospectus,
there are no outstanding options, warrants or other rights to purchase, agreements or other obligations to issue, or rights to convert
any obligations into or exchange any securities or interests for capital stock or other ownership interests of any Subsidiary of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company&rsquo;s authorized equity capitalization is as set forth in the Registration Statement, the Disclosure Package and the Prospectus
under the heading &ldquo;Capitalization&rdquo;; the capital stock of the Company conforms in all material respects to the description
thereof contained in the Registration Statement, the Disclosure Package and the Prospectus; the outstanding shares of capital stock of
the Company have been duly and validly authorized and issued and are fully paid and non-assessable; the Shares have been duly and validly
authorized, and, when issued and delivered to and paid for by the Underwriters pursuant to the terms of this Agreement, will be fully
paid and non-assessable; the Shares are duly listed, and admitted and authorized for trading, subject to official notice of issuance and
evidence of satisfactory distribution, on the Nasdaq Capital Market; the certificates for the Shares are in valid and sufficient form;
the holders of outstanding shares of capital stock of the Company are not entitled to preemptive or other rights to subscribe for the
Securities or the Warrant Shares; except as set forth in the Registration Statement, the Disclosure Package and the Prospectus, no options,
warrants or other rights to purchase, agreements or other obligations to issue, or rights to convert any obligations into or exchange
any securities for, shares of capital stock of or ownership interests in the Company are outstanding; and all offers and sales by the
Company of the Company&rsquo;s shares of Common Stock prior to the date hereof were at all relevant times duly registered under the Act
or were exempt from the registration requirements of the Act and were duly registered or the subject of an available exemption from the
registration requirements of the applicable state securities or blue sky laws. No holder of the Securities will be subject to personal
liability for obligations of the Company solely by reason of being such a holder. The Pre-Funded Warrants have been duly authorized by
the Company and, when executed and delivered by the Company pursuant to this Agreement, will constitute valid, legal and binding obligations
of the Company, enforceable in accordance with their terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization
or similar laws affecting the rights of creditors generally and subject to general principles of equity. The Warrant Shares have been
duly authorized and validly reserved for issuance upon exercise of the Pre-Funded Warrants in a number sufficient to meet the current
exercise requirements and, when issued and delivered in accordance with the terms thereof, will be validly issued, fully paid and nonassessable,
and the holders thereof will not be subject to personal liability by reason of being such holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Agreement has been duly authorized, executed and delivered by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company is not and, immediately after giving effect to the offering and sale of the Securities and the application of the proceeds thereof
as described in the Registration Statement, the Disclosure Package and the Prospectus, will not be an &ldquo;investment company&rdquo;
or an entity &ldquo;controlled&rdquo; by an &ldquo;investment company&rdquo;, in each case, as defined in the Investment Company Act of
1940, as amended, and the rules&nbsp;and regulations of the Commission thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
consent, approval, authorization, filing with, license, registration, qualification or order of any court or governmental agency or body
is required in connection with the transactions contemplated herein or in the Pre-Funded Warrants, except such as have been obtained under
the Act and such as may be required under the blue sky laws of any jurisdiction in connection with the purchase and distribution of the
Securities and, upon exercise of the Pre-Funded Warrants, the Warrant Shares by the Underwriters in the manner contemplated herein or
therein and in the Registration Statement, the Disclosure Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the issue and sale of the Securities and, upon exercise of the Pre-Funded Warrants, the Warrant Shares nor the consummation of any other
of the transactions contemplated herein or in the Pre-Funded Warrants nor the fulfillment of the terms hereof or thereof will conflict
with, result in a breach or violation of, or constitute a default under, result in the termination, modification or acceleration of, or
imposition of any lien, charge or encumbrance upon any property or assets of the Company or any of its Subsidiaries pursuant to, (i)&nbsp;the
charter, by-laws or similar organizational documents of the Company or any of its Subsidiaries, (ii)&nbsp;the terms of any indenture,
contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation, condition, covenant or instrument
to which the Company or any of its Subsidiaries is a party or bound or to which its or their property is subject or (iii)&nbsp;any statute,
law, rule, regulation, judgment, order or decree applicable to the Company or any of its Subsidiaries of any court, regulatory body, administrative
agency, governmental body, arbitrator or other authority having jurisdiction over the Company or any of its Subsidiaries or any of its
or their properties, except, in the case of clauses (ii)&nbsp;and (iii)&nbsp;above, for any such conflict, breach, violation, default,
lien, charge or encumbrance that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any Subsidiary is in violation or default of (i)&nbsp;any provision of its charter, bylaws or similar organizational documents,
(ii)&nbsp;the terms of any indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation,
condition, covenant or instrument to which it is a party or bound or to which its property is subject, or (iii)&nbsp;any statute, law,
rule, regulation, judgment, order, writ or decree of any court, regulatory body, administrative agency, governmental body, arbitrator
or other authority having jurisdiction over the Company or such Subsidiary or any of its properties, assets or operations, as applicable,
except, in the case of clauses (ii)&nbsp;and (iii)&nbsp;above, for any such default or violation that would not, individually or in the
aggregate, have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
holders of securities of the Company or its Subsidiaries have rights to require the registration of such securities under the Act by reason
of the filing of the Registration Statement with the Commission or the issuance and sale of the Securities and, upon exercise of the Pre-Funded
Warrants, the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
consolidated historical financial statements, including the notes thereto, of the Company and its consolidated subsidiaries included or
incorporated by reference in the Registration Statement, the Preliminary Prospectus and the Prospectus present fairly the financial condition,
results of operations and cash flows of the Company as of the dates and for the periods indicated (subject to normal year-end audit adjustments
for interim financial statements), and have been prepared in compliance with the applicable accounting requirements of the Act and the
Exchange Act, as applicable, and in conformity with U.S. generally accepted accounting principles (&ldquo;<U>GAAP</U>&rdquo;) applied
on a consistent basis throughout the periods involved (except for such adjustments to accounting standards and practices as otherwise
noted therein). All non-GAAP financial information included or incorporated by reference in the Registration Statement, the Disclosure
Package and the Prospectus complies with the requirements of Regulation G and Item 10 of Regulation S-K under the Act, to the extent applicable;
and, except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, there are no material off-balance sheet
arrangements (as defined in Regulation S-K under the Act,&nbsp;Item 303(a)(4)(ii)) or any other relationships with unconsolidated entities
or other persons, that could reasonably be expected to affect materially the Company&rsquo;s liquidity or the availability of or requirements
for its capital resources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
action, suit, inquiry or proceeding brought by or before any court or governmental agency, authority or body or any arbitrator (&ldquo;<U>Actions</U>&rdquo;)
involving the Company or any of its Subsidiaries or its or their property is pending or, to the best knowledge of the Company, threatened
that&nbsp;could reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, except as set forth in or
contemplated in the Registration Statement, the Disclosure Package and the Prospectus (exclusive of any supplement thereto). There are
no current or pending Actions that are required under the Act to be described in the Registration Statement, the Disclosure Package and
the Prospectus that are not so described therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
of the Company and each of its Subsidiaries owns or leases all such properties as are necessary to the conduct of its operations as presently
conducted except where failure to do so would not be reasonably expected, individually or in the aggregate, to have a Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Ernst&nbsp;&amp;
Young LLP, who have certified certain financial statements of the Company and its consolidated subsidiaries and delivered their report
with respect to the audited consolidated financial statements and schedules included or incorporated by reference in the Registration
Statement, the Disclosure Package and the Prospectus, are independent public accountants with respect to the Company within the meaning
of the Act and the applicable published rules&nbsp;and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">There
are no transfer taxes or other similar fees or charges under Federal law or the laws of any state, or any political subdivision thereof,
required to be paid in connection with the execution and delivery of this Agreement and the Pre-Funded Warrants or the issuance, sale
or delivery by the Company of the Securities and, upon exercise of the Pre-Funded Warrants, the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and each of its Subsidiaries has filed all federal, state and foreign income and franchise tax returns that are required to be
filed or has requested extensions thereof (except in any case in which the failure so to file would not, individually or in the aggregate,
have a Material Adverse Effect and except as set forth in or contemplated in the Registration Statement, the Disclosure Package and the
Prospectus (exclusive of any supplement thereto)) and has paid all taxes required to be paid by it and any other assessment, fine or penalty
levied against it, to the extent that any of the foregoing is due and payable, except (i)&nbsp;for any such assessment, fine or penalty
that is currently being contested in good faith and for which adequate reserves have been provided in accordance with GAAP or as would
not have a Material Adverse Effect, or (ii)&nbsp;as set forth in or contemplated in the Registration Statement, the Disclosure Package
and the Prospectus (exclusive of any supplement thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
labor problem or dispute with the employees of the Company or any of its Subsidiaries exists or, to the knowledge of the Company, is threatened
or imminent, which would reasonably be expected to result in a Material Adverse Effect, except as set forth in or contemplated in the
Registration Statement, the Disclosure Package and the Prospectus (exclusive of any supplement thereto). Subsidiaries</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and each of its Subsidiaries are insured by reputable insurers of recognized financial responsibility against such losses and
risks and in such amounts as are prudent and customary in the businesses in which they are engaged; all policies of insurance insuring
the Company or any of its Subsidiaries or their respective businesses, assets, employees, officers and directors are in full force and
effect; and neither the Company nor any such Subsidiary has any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business
at a cost that would not have a Material Adverse Effect, except in each case as set forth in or contemplated in the Registration Statement,
the Disclosure Package and the Prospectus (exclusive of any supplement thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bb)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
Subsidiary of the Company is currently prohibited or restricted, directly or indirectly, from paying any dividends to the Company, from
making any other distribution on such Subsidiary&rsquo;s capital stock or other ownership interest, from repaying to the Company any
loans or advances to such Subsidiary from the Company or from transferring any of such Subsidiary&rsquo;s property or assets to the Company
or any other Subsidiary of the Company, except as described in or contemplated by the Registration Statement, the Disclosure Package
and the Prospectus (exclusive of any supplement thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(cc)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and its Subsidiaries possess all licenses, certificates, permits and other authorizations issued by all applicable authorities
necessary to conduct their respective businesses. The Company and its Subsidiaries are in compliance with the terms of such licenses,
certificates, permits and other authorizations, except where the failure to so comply would not, individually or in the aggregate, be
reasonably expected to have a Material Adverse Effect. Neither the Company nor any such Subsidiary has received any notice of proceedings
relating to the revocation or modification of any such certificate, authorization or permit which, individually or in the aggregate, if
the subject of an unfavorable decision, ruling or finding, would have a Material Adverse Effect, except as set forth in or contemplated
in the Registration Statement, the Disclosure Package and the Prospectus (exclusive of any supplement thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(dd)</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and its Subsidiaries maintain a system of &ldquo;internal control over financial reporting&rdquo; (as defined in Rule&nbsp;13a-15(f)&nbsp;of
the Exchange Act) that comply with the requirements of the Exchange Act and have been designed by, or under the supervision of, their
respective principal executive and principal financial officers, or persons performing similar functions, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with
GAAP. The Company and its Subsidiaries maintain internal accounting controls sufficient to provide reasonable assurance that (i)&nbsp;transactions
are executed in accordance with management&rsquo;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary
to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability; (iii)&nbsp;access to assets
is permitted only in accordance with management&rsquo;s general or specific authorization; and (iv)&nbsp;the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
The Company and its Subsidiaries&rsquo; internal controls over financial reporting are effective and the Company and its Subsidiaries
are not aware of any material weakness in their internal controls over financial reporting. The Company&rsquo;s independent auditors
and board of directors have been advised of: (i)&nbsp;all &ldquo;material weaknesses&rdquo; and &ldquo;significant deficiencies&rdquo;
(each, as defined in Rule&nbsp;12b-2 of the Exchange Act), if any, in the design or operation of internal controls which could adversely
affect the Company&rsquo;s ability to record, process, summarize and report financial data and (ii)&nbsp;all fraud, if any, whether or
not material, that involves management or other employees who have a role in the Company&rsquo;s internal controls (whether or not remediated);
all such material weaknesses and significant deficiencies, if any, have been disclosed in the Registration Statement, the Disclosure
Package and the Prospectus in all material respects; and since the date of the most recent evaluation of such disclosure controls and
procedures and internal controls, there have been no significant changes in internal controls or in other factors that could significantly
affect internal controls, including any corrective actions with regard to significant deficiencies and material weaknesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ee)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and its Subsidiaries maintain &ldquo;disclosure controls and procedures&rdquo; (as such term is defined in Rule&nbsp;13a-15(e)&nbsp;under
the Exchange Act) that (i)&nbsp;are designed to ensure that material information relating to the Company and its Subsidiaries is made
known to the Company&rsquo;s principal executive officer and its principal financial officer by others within those entities, especially
during the periods in which the periodic reports required under the Exchange Act are being prepared, (ii)&nbsp;have been evaluated by
management of the Company for effectiveness as of the end of the Company&rsquo;s most recent fiscal quarter, and (iii)&nbsp;are effective
in all material respects to perform the functions for which they were established. Since the end of the Company&rsquo;s most recent audited
fiscal year, there have been no significant deficiencies or material weaknesses in the Company&rsquo;s internal control over financial
reporting, whether or not remediated, and no change in the Company&rsquo;s internal control over financial reporting that has materially
affected, or is reasonably likely to materially affect, the Company&rsquo;s internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ff)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has not taken, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to
cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(gg)</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(i)&nbsp;The
Company and its Subsidiaries and their respective properties, assets and operations are in compliance with, and the Company and its Subsidiaries
hold all permits, authorizations and approvals required under, Environmental Laws (as defined below), except to the extent that failure
to so comply or to hold such permits, authorizations or approvals would not, individually or in the aggregate, have a Material Adverse
Effect; there are no past, present or, to the Company&rsquo;s knowledge, reasonably anticipated future events, conditions, circumstances,
activities, practices, actions, omissions or plans that would reasonably be expected to give rise to any material costs or liabilities
to the Company or its Subsidiaries under, or to interfere with or prevent compliance by the Company or its Subsidiaries with, Environmental
Laws; except as would not, individually or in the aggregate, have a Material Adverse Effect, neither the Company nor its Subsidiaries
(i)&nbsp;is the subject of any investigation, (ii)&nbsp;has received any notice or claim, (iii)&nbsp;is a party to or affected by any
pending or, to the Company&rsquo;s knowledge, threatened action, suit or proceeding, (iv)&nbsp;is bound by any judgment, decree or order
or (v)&nbsp;has entered into any agreement, in each case relating to any alleged violation of any Environmental Law or any actual or
alleged release or threatened release or cleanup at any location of any Hazardous Materials (as defined below) (as used herein, &ldquo;<U>Environmental
Law</U>&rdquo; means any federal, state, local or foreign law, statute, ordinance, rule, regulation, order, decree, judgment, injunction,
permit, license, authorization or other binding requirement, or common law, relating to health, safety or the protection, cleanup or
restoration of the environment or natural resources, including those relating to the distribution, processing, generation, treatment,
storage, disposal, transportation, other handling or release or threatened release of Hazardous Materials, and &ldquo;<U>Hazardous Materials</U>&rdquo;
means any material (including, without limitation, pollutants, contaminants, hazardous or toxic substances or wastes) that is regulated
by or may give rise to liability under any Environmental Law).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(hh)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
 &ldquo;employee benefit plan&rdquo; (within the meaning of Section&nbsp;3(3)&nbsp;of the Employee Retirement Security Act of 1974, as
amended (&ldquo;<U>ERISA</U>&rdquo;)) for which the Company or any member of its &ldquo;<U>Controlled Group</U>&rdquo; (defined as any
organization which is a member of a controlled group of corporations within the meaning of Section&nbsp;414 of the Code) would have any
liability (each, a &ldquo;<U>Plan</U>&rdquo;) complies in form with the requirements of all applicable statutes, rules&nbsp;and regulations
including ERISA and the Code, and has been maintained and administered in substantial compliance with its terms and with the requirements
of all applicable statutes, rules&nbsp;and regulations including ERISA and the Code;; no prohibited transaction, within the meaning of
Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code, has occurred with respect to any Plan excluding transactions to which a statutory
or administrative prohibited transaction exemption applies; and for each such Plan that is subject to the funding rules&nbsp;of Section&nbsp;412
of the Code or Section&nbsp;302 of ERISA, no &ldquo;accumulated funding deficiency&rdquo; as defined in Section&nbsp;412 of the Code
has been incurred, whether or not waived, and the fair market value of the assets of each such plan (excluding for these purposes accrued
but unpaid contributions) exceeds the present value of all benefits accrued under such plan determined using reasonable actuarial assumptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">There
is and has been no failure on the part of the Company and any of the Company&rsquo;s directors or officers, in their capacities as such,
to comply with any provision of the Sarbanes-Oxley Act of 2002 and the rules&nbsp;and regulations promulgated in connection therewith
(the &ldquo;<U>Sarbanes-Oxley Act</U>&rdquo;), including Section&nbsp;402 relating to loans and Sections 302 and 906 relating to certifications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(jj)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor the Subsidiaries, nor any director or officer of the Company or any Subsidiary nor, to the Company&rsquo;s knowledge,
any employee of the Company or any Subsidiary, agent, affiliate or other person acting on behalf of the Company or any Subsidiary has,
in the past five years, made any unlawful contributions to any candidate for any political office (or failed fully to disclose any contribution
in violation of applicable law) or made any contribution or other payment to any official of, or candidate for, any federal, state, municipal,
or foreign office or other person charged with similar public or quasi-public duty in violation of any applicable law or of the character
required to be disclosed in the Prospectus; (ii)&nbsp;no relationship, direct or indirect, exists between or among the Company or any
Subsidiary or, to the Company&rsquo;s knowledge, any affiliate of any of them, on the one hand, and the directors, officers and stockholders
of the Company or any Subsidiary, on the other hand, that is required by the Act to be described in the Registration Statement and the
Prospectus that is not so described; and (iii)&nbsp;neither the Company nor any Subsidiary nor any director, officer or employee of the
Company or any Subsidiary nor, to the Company&rsquo;s knowledge, any agent, affiliate or other person acting on behalf of the Company
or any Subsidiary has (A)&nbsp;violated or is in violation of any applicable provision of the U.S. Foreign Corrupt Practices Act of 1977,
as amended, or any other applicable anti-bribery or anti-corruption law (collectively, &ldquo;<U>Anti-Corruption Laws</U>&rdquo;), (B)&nbsp;promised,
offered, provided, attempted to provide or authorized the provision of anything of value, directly or indirectly, to any person for the
purpose of obtaining or retaining business, influencing any act or decision of the recipient, or securing any improper advantage; or (C)&nbsp;made
any payment of funds of the Company or any Subsidiary or received or retained any funds in violation of any Anti-Corruption Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(kk)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record
keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes
of all jurisdictions to which the Company or its Subsidiaries are subject, the rules&nbsp;and regulations thereunder and any related or
similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &ldquo;<U>Money
Laundering Laws</U>&rdquo;); and no action, suit or proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company or any of its Subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge
of the Company, threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ll)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(i)&nbsp;The
Company represents that, neither the Company nor any of its Subsidiaries (collectively, the &ldquo;<U>Entity</U>&rdquo;) or, to the Company&rsquo;s
knowledge, any director, officer, employee, agent, affiliate or representative of the Entity, is a government, individual, or entity (in
this paragraph (ll), &ldquo;<U>Person</U>&rdquo;) that is, or is owned or controlled by a Person that is (A)&nbsp;the subject of any sanctions
administered or enforced by the U.S. Department of Treasury&rsquo;s Office of Foreign Assets Control (&ldquo;<U>OFAC</U>&rdquo;), the
United Nations Security Council, the European Union, His Majesty&rsquo;s Treasury, or other relevant sanctions authorities, including,
without limitation, designation on OFAC&rsquo;s Specially Designated Nationals and Blocked Persons List or OFAC&rsquo;s Foreign Sanctions
Evaders List (as amended, collectively, &ldquo;<U>Sanctions</U>&rdquo;), nor (B)&nbsp;located, organized or resident in a country or territory
that is the subject of Sanctions that broadly prohibit dealings with that country or territory (including, without limitation, Cuba,&nbsp;Iran,
North Korea, Syria and the Crimea Region of the Ukraine) (the &ldquo;<U>Sanctioned Countries</U>&rdquo;); (ii)&nbsp;the Entity represents
and covenants that it will not, directly or indirectly, use the proceeds of the offering, or lend, contribute or otherwise make available
such proceeds to any subsidiary, joint venture partner or other Person (A)&nbsp;to fund or facilitate any activities or business of or
with any Person or in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions or is a
Sanctioned Country; or (B)&nbsp; in any other manner that will result in a violation of Sanctions by any Person (including any Person
participating in the offering, whether as underwriter, advisor, investor or otherwise); (iii)&nbsp;the Entity represents and covenants
that, except as detailed in the Registration Statement and the Prospectus, for the past five years, it has not engaged in, is not now
knowingly engaging in, and will not knowingly engage in, any dealings or transactions with any Person, or in any country or territory,
that at the time of the dealing or transaction is or was the subject of Sanctions or is or was a Sanctioned Country.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(mm)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and its Subsidiaries&rsquo; information technology assets and equipment, computers, systems, networks, hardware, software, websites,
applications, and databases (collectively, &ldquo;<U>IT Systems</U>&rdquo;) are adequate for, and operate and perform in all material
respects as required in connection with the operation of the business of the Company as currently conducted, free and clear of all material
bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The Company and its Subsidiaries have implemented and
maintained commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards to maintain and
protect their material confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and
data, including all &ldquo;Personal Data&rdquo; (defined below) and all sensitive, confidential or regulated data (&ldquo;<U>Confidential
Data</U>&rdquo;) used in connection with their businesses. &ldquo;<U>Personal Data</U>&rdquo; means (i)&nbsp;a natural person&rsquo;s
name, street address, telephone number, e-mail address, photograph, social security number or tax identification number, driver&rsquo;s
license number, passport number, credit card number, bank information, or customer or account number; (ii)&nbsp;any information which
would qualify as &ldquo;personally identifying information&rdquo; under the Federal Trade Commission Act, as amended; (iii)&nbsp;&ldquo;personal
data&rdquo; as defined by GDPR (defined below); (iv)&nbsp;any information which would qualify as &ldquo;protected health information&rdquo;
under the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and
Clinical Health Act (collectively, &ldquo;<U>HIPAA</U>&rdquo;); (v)&nbsp;any &ldquo;personal information&rdquo; as defined by the California
Consumer Privacy Act (&ldquo;<U>CCPA</U>&rdquo;); and (vi)&nbsp;any other piece of information that allows the identification of such
natural person, or his or her family, or permits the collection or analysis of any data related to an identified person&rsquo;s health
or sexual orientation. There have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those
that have been remedied without material cost or liability or the duty to notify any other person, nor any incidents under internal review
or investigations relating to the same. The Company and its Subsidiaries are presently in material compliance with all applicable laws
or statutes and all judgments, orders, rules&nbsp;and regulations of any court or arbitrator or governmental or regulatory authority,
internal policies and contractual obligations relating to the privacy and security of IT Systems, Confidential Data, and Personal Data
and to the protection of such IT Systems, Confidential Data, and Personal Data from unauthorized use, access, misappropriation or modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(nn)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and its Subsidiaries are, and at all prior times were, in material compliance with all applicable state and federal data privacy
and security laws and regulations, including without limitation HIPAA, CCPA, and the European Union General Data Protection Regulation
(&ldquo;<U>GDPR</U>&rdquo;) (EU 2016/679) (collectively, the &ldquo;<U>Privacy Laws</U>&rdquo;). To ensure compliance with the Privacy
Laws, the Company has in place, complies with, and takes appropriate steps to ensure compliance in all material respects with their policies
and procedures relating to data privacy and security and the collection, storage, use, processing, disclosure, handling, and analysis
of Personal Data and Confidential Data (the &ldquo;<U>Policies</U>&rdquo;). The Company has at all times made all disclosures to users
or customers required by applicable laws and regulatory rules&nbsp;or requirements, and none of such disclosures made or contained in
any Policy have been inaccurate or in violation of any applicable laws and regulatory rules&nbsp;or requirements in any material respect.
The Company further certifies that neither it nor any Subsidiary: (i)&nbsp;has received notice of any actual or potential liability under
or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would
reasonably be expected to result in any such notice; (ii)&nbsp;is currently conducting or paying for, in whole or in part, any investigation,
remediation, or other corrective action pursuant to any Privacy Law; or (iii)&nbsp;is a party to any order, decree, or agreement that
imposes any obligation or liability under any Privacy Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(oo)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
interactive data in the eXtensible Business Reporting Language (&ldquo;<U>XBRL</U>&rdquo;) included as an exhibit to or incorporated by
reference in the Registration Statement fairly presents the information called for in all material respects and has been prepared in accordance
with the Commission&rsquo;s rules&nbsp;and guidelines applicable thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(pp)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as set forth in the Registration Statement, the Disclosure Package and the Prospectus, the Company and its Subsidiaries have good and
marketable title to all personal property owned by them, free and clear of all encumbrances and defects except those that (i)&nbsp;do
not materially interfere with the use made and proposed to be made of such property by the Company and any of its Subsidiaries or (ii)&nbsp;would
not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. Any real or personal property described
in the Registration Statement, the Disclosure Package or the Prospectus as being leased by the Company and any of its Subsidiaries is
held by them under valid, existing and enforceable leases, except those matters that (A)&nbsp;do not materially interfere with the use
made or proposed to be made of such property by the Company or any of its Subsidiaries or (B)&nbsp;would not, individually or in the aggregate,
have a Material Adverse Effect. .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(qq)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
relationship, direct or indirect, exists between or among the Company or any of its Subsidiaries on the one hand, and the directors,
officers, or shareholders of the Company on the other hand, which is required to be described in the Registration Statement, the Disclosure
Package and the Prospectus and which is not so described.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(rr)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Subsidiaries listed on Schedule IV attached hereto are the only significant Subsidiaries of the Company as defined by Rule&nbsp;1-02 of
Regulation S-X.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ss)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
statistical and market-related data included or incorporated by reference in the Registration Statement, the Disclosure Package and the
Prospectus are based on or derived from sources that the Company believes to be reliable and accurate. To the extent required, the Company
has obtained written consent to the use of such data from such sources.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(tt)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the issuance, sale and delivery of the Securities and, upon exercise of the Pre-Funded Warrants, the Warrant Shares nor the application
of the proceeds thereof by the Company as described in each of the Registration Statement, the Disclosure Package and the Prospectus will
violate Regulation&nbsp;T, U or X of the Board of Governors of the Federal Reserve System.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(uu)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Since
the date of the most recent financial statements of the Company included or incorporated by reference in each of the Registration Statement,
the Disclosure Package and the Prospectus (i)&nbsp;there has not been any change in the capital stock or long-term debt of the Company
or any of its Subsidiaries, or any dividend or distribution of any kind declared, set aside for payment, paid or made by the Company
on any class of capital stock, or any material adverse change, or any development involving a prospective material adverse change, in
or affecting the business, properties, prospects, earnings, rights, assets, management, financial position, or results of operations
of the Company and its Subsidiaries taken as a whole; (ii)&nbsp;neither the Company nor any of its Subsidiaries has entered into any
transaction or agreement that is material to the Company and its Subsidiaries taken as a whole or incurred any liability or obligation,
direct or contingent, that is material to the Company and its Subsidiaries taken as a whole; and (iii)&nbsp;neither the Company nor any
of its Subsidiaries has sustained any material loss or interference with its business from fire, explosion, flood or other calamity,
whether or not covered by insurance, or from any labor disturbance or dispute or any action, order or decree of any court or arbitrator
or governmental or regulatory authority, except in each case as otherwise disclosed in each of the Registration Statement, the Disclosure
Package and the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vv)</FONT>&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
forward-looking statement (within the meaning of Section&nbsp;27A of the Act and Section&nbsp;21E of the Exchange Act) included in any
of the Registration Statement, the Disclosure Package and the Prospectus has been made or reaffirmed without a reasonable basis or has
been disclosed other than in good faith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ww)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as disclosed in the Registration Statement, the Preliminary Prospectus and the Prospectus, the Company and its Subsidiaries own, possess,
license or have other rights to use all patents, patent applications, trade and service marks, trade and service mark registrations, trade
names, copyrights, licenses, inventions, trade secrets, technology, know-how and other intellectual property (collectively, the &ldquo;<U>Intellectual
Property</U>&rdquo;), which to the Company&rsquo;s knowledge, is necessary for the conduct of the Company&rsquo;s business as now conducted
except to the extent that the failure to own, possess, license or otherwise hold adequate rights to use such Intellectual Property would
not, individually or in the aggregate, have a Material Adverse Effect.. Except as set forth in the Registration Statement, the Preliminary
Prospectus and the Prospectus (a)&nbsp;there are no rights of third parties to any Intellectual Property that is owned by the Company,
other than any co-owner of any patent or patent application constituting Intellectual Property who is listed as such on the records of
the U.S. Patent and Trademark Office; (b)&nbsp;to the Company&rsquo;s knowledge, there is no material infringement by third parties of
any such Intellectual Property; (c)&nbsp;there is no pending or, to the knowledge of the Company, threatened action, suit, proceeding
or claim by others challenging the Company&rsquo;s rights in or to any such Intellectual Property, and the Company is unaware of any facts
which would form a reasonable basis for any such claim; (d)&nbsp;there is no pending or, to the knowledge of the Company, threatened action,
suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property, and the Company is unaware of
any facts which would form a reasonable basis for any such claim; and (e)&nbsp;there is no pending or threatened action, suit, proceeding
or claim by others that the Company infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary
rights of others, except, in the case of any of clauses (a)-(e)&nbsp;above, for any such infringement by third parties or any such pending
or threatened suit, action, proceeding or claim as would not, individually or in the aggregate, reasonably be expected to result in a
Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xx)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as disclosed in the Registration Statement, the Disclosure Package and the Prospectus, the Company (i)&nbsp;does not have any&nbsp;material
lending or other relationship with any bank or lending affiliate of the Representatives and (ii)&nbsp;does not intend to use any of the
proceeds from the sale of the Securities (or from the exercise of the Pre-Funded Warrants) hereunder to repay any outstanding debt owed
to any affiliate of the Representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(yy)</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as otherwise disclosed in the Registration Statement, the Disclosure Package and the Prospectus, (i)&nbsp;the Company and its Subsidiaries
have fee simple title to or leasehold interest in all of the properties described in the Registration Statement, the Disclosure Package
and the Prospectus as owned or leased by them and the improvements (exclusive of improvements owned by tenants) located thereon (the
 &ldquo;<U>Properties</U>&rdquo;), in each case, free and clear of all liens, encumbrances, claims, security interests, restrictions and
defects, except such as are disclosed in the Registration Statement, the Disclosure Package and the Prospectus or do not materially affect
the value of such Property and do not materially interfere with the use made and proposed to be made of such Property by the Company
and any Subsidiary or would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect; (ii)&nbsp;neither
the Company nor any of its Subsidiaries knows of any condemnation which is threatened and which if consummated would reasonably be expected
to have a Material Adverse Effect; (iii)&nbsp;to the best of the Company&rsquo;s knowledge, each of the Properties complies with all
applicable codes, laws and regulations (including without limitation, building and zoning codes, laws and regulations and laws relating
to access to the Properties), except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus and except
for such failures to comply that would not individually or in the aggregate reasonably be expected to materially affect the value of
such Property or interfere in any material respect with the use made and proposed to be made of such Property by the Company or any Subsidiary;
and (iv)&nbsp;to the knowledge of the Company, except as set forth in or contemplated in the Registration Statement, the Disclosure Package
and the Prospectus and, with respect to (A)&nbsp;below, except as would not individually or in the aggregate reasonably be expected to
materially affect the value of such Property or interfere in any material respect with the use made and proposed to be made of such Property
by the Company or any Subsidiary: (A)&nbsp;there are no uncured events of default, or events that with the giving of notice or passage
of time, or both, would constitute an event of default by any tenant under any of the terms and provisions of any lease described in
the &ldquo;Properties&rdquo; section of the Registration Statement; and (B)&nbsp;no tenant under any of the leases at the Properties
has a right of first refusal to purchase the premises demised under such lease.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(zz)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
preclinical studies and clinical trials that are described in, or the results of which are referred to in, the Registration Statement,
the Disclosure Package and the Prospectus were and, if still pending, are being conducted in all material respects in accordance with
standard accepted medical and scientific research procedures and all applicable Laws, including, but not limited to, the Federal Food,
Drug and Cosmetic Act (the &ldquo;<U>FDCA</U>&rdquo;) and its applicable implementing regulations at 21 C.F.R. Parts 50, 54, 56, 58 and
312; the descriptions of and information regarding the results of such studies, tests and trials, and the data and results derived therefrom,
described in the Registration Statement, the Disclosure Package and the Prospectus are accurate and complete, as of the date indicated,
in all material respects and fairly present the data derived from such tests and trials, and neither the Company nor its Subsidiaries,
after due inquiry, has any knowledge of any other studies, tests, trials, publications, presentations or other information relating to
the Company&rsquo;s products or product candidates not described in the Registration Statement, the Disclosure Package and the Prospectus
the results of which reasonably call into question the results described or referred to in the Registration Statement, the Disclosure
Package and the Prospectus; neither the Company nor its Subsidiaries has received any notices or other correspondence from the Food and
Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government
or drug or medical device regulatory agency (collectively, the &ldquo;<U>Regulatory Agencies</U>&rdquo;) requiring or threatening the
termination, suspension or material modification of any studies, tests or trials that are described or referred to in the Registration
Statement, the Disclosure Package and the Prospectus; and the Company and its Subsidiaries have operated and currently are in compliance
in all material respects with all applicable rules, regulations and policies of the Regulatory Agencies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aaa)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not, individually or in the aggregate, have or may reasonably be expected to have a Material Adverse Effect: (i)&nbsp;neither
the Company nor its Subsidiaries has received any written notice of adverse filing, warning letter, untitled letter or other correspondence
or notice from any Regulatory Agency or other relevant regulatory authorities, or any other court or arbitrator or federal, state, local
or foreign governmental or regulatory authority, alleging or asserting material noncompliance with the Federal Food, Drug and Cosmetic
Act (21 U.S.C. &sect; 301 et seq.) or similar state, federal or foreign law or regulation; (ii)&nbsp;the Company and its Subsidiaries,
and to the Company&rsquo;s knowledge, their respective directors, officers, employees or agents, are and have been since January&nbsp;1,
2016 in compliance in all material respects with applicable health care laws, including without limitation, the Federal Food, Drug and
Cosmetic Act (21 U.S.C. &sect; 301 et seq.), the federal Anti-Kickback Statute (42 U.S.C. &sect; 1320a-7b(b)), the Civil Monetary Penalties
Law (42 U.S.C. &sect; 1320a-7a), the U.S. Civil False Claims Act (31 U.S.C. &sect; 3729 et seq.), 18 U.S.C. &sect;&sect; 286 and 287,
and the health care fraud criminal provisions under HIPAA (42 U.S.C. &sect; 1320d et seq.), the exclusion laws (42 U.S.C. &sect; 1320a-7),
Medicare (Title XVIII of the Social Security Act), Medicaid (Title XIX of the Social Security Act), HIPAA, as amended by the Health Information
Technology for Economic and Clinical Health Act (42 U.S.C. &sect; 17921 et seq.), each as amended, and the regulations promulgated thereunder;
and all other comparable local, state, federal, national, supranational and foreign laws, and the regulations promulgated thereunder,
(collectively, &ldquo;<U>Health Care Laws</U>&rdquo;); (iii)&nbsp;neither the Company nor its Subsidiaries has received written notice
of any ongoing claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any U.S. or non-U.S.
federal, national, state, provincial, local, municipal, international government or other governmental, administrative or regulatory authority,
governmental, administrative or regulatory agency or body, department, board, bureau, agency or instrumentality, court, tribunal, arbitrator
or arbitral body (public or private) or self-regulatory organization (each, a &ldquo;<U>Governmental Authority</U>&rdquo;) or third party
alleging that any product, operation or activity is in violation of any Health Care Laws or has any knowledge that any such Governmental
Authority or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding; (iv)&nbsp;neither
the Company nor its Subsidiaries or any of their respective directors, officers, employees or, to the Company&rsquo;s knowledge, agents,
is or has been debarred, suspended or excluded, or has been convicted of any crime or engaged in any conduct that would result in a debarment,
suspension or exclusion from any federal or state government health care program; and (v)&nbsp;the Company and its Subsidiaries are not
a party to nor have any ongoing reporting obligations pursuant to any corporate integrity agreement, deferred prosecution agreement, monitoring
agreement, consent decree, settlement order, plan of correction or similar agreement imposed by any Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(bbb)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
pursuant to this Agreement, there is no broker, finder or other party that is entitled to receive from the Company any brokerage or finder&rsquo;s
fee or other fee or commission as a result of any transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any certificate signed by
any officer of the Company and delivered to the Representatives or counsel for the Underwriters in connection with the offering of the
Securities shall be deemed a representation and warranty by the Company, as to matters covered thereby, to each Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">2.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Purchase
and Sale.</U> (a)&nbsp; Subject to the terms and conditions and in reliance upon the representations and warranties herein set forth,
the Company agrees to sell to each Underwriter, and each Underwriter agrees, severally and not jointly, to purchase from the Company the
number of Underwritten Shares and Pre-Funded Warrants set forth opposite the name of such Underwriter in Schedule I hereto. The purchase
price for each Underwritten Share shall be $9.165 per share and the purchase price for the Pre-Funded Warrants shall be $9.164 per Pre-Funded
Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Subject
to the terms and conditions and in reliance upon the representations and warranties herein set forth, the Company hereby grants an option
to the several Underwriters to purchase, severally and not jointly, up to 1,308,000 Option Securities at the same purchase price per
share as the Underwriters shall pay for the Underwritten Shares, less an amount per share equal to any dividends or distributions declared
by the Company and payable on the Underwritten Shares but not payable on the Option Securities. Said option may be exercised in whole
or in part at any time on or before the 30th day after the date of the Prospectus upon written or telegraphic notice by the Representatives
to the Company setting forth the number of shares of the Option Securities as to which the several Underwriters are exercising the option
and the Settlement Date. The number of Option Securities to be purchased by each Underwriter shall be the same percentage of the total
number of shares of the Option Securities to be purchased by the several Underwriters as such Underwriter is purchasing of the Underwritten
Shares, subject to such adjustments as you in your absolute discretion shall make to eliminate any fractional shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Delivery
and Payment.</U></FONT> Delivery of and payment for the Underwritten Securities and the Option Securities (if the option provided for
in Section&nbsp;2(b)&nbsp;hereof shall have been exercised on or before the second Business Day immediately preceding the Closing Date)
shall be made at 10:00&nbsp;AM, New York City time, on June&nbsp;21, 2023, or at such time on such later date not more than two Business
Days after the foregoing date as the Representatives shall designate, which date and time may be postponed by agreement between the Representatives
and the Company or as provided in Section&nbsp;8 hereof (such date and time of delivery and payment for the Securities being herein called
the &ldquo;<U>Closing Date</U>&rdquo;). Delivery of the Securities shall be made to the Representatives for the respective accounts of
the several Underwriters against payment by the several Underwriters through the Representatives of the purchase price thereof to or upon
the order of the Company by wire transfer payable in same-day funds to an account specified by the Company. Delivery of the Underwritten
Securities and the Option Securities shall be made through the facilities of The Depository Trust Company unless the Representatives shall
otherwise instruct. &ldquo;Business Day&rdquo; shall mean any day&nbsp;other than a Saturday, a Sunday or a legal holiday or a day on
which banking institutions or trust companies are authorized or obligated by law to close in New York City.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the option provided for
in Section&nbsp;2(b)&nbsp;hereof is exercised after the second Business Day immediately preceding the Closing Date, the Company will deliver
the Option Securities (at the expense of the Company) to the Representatives, at RBC Capital Markets, LLC, 200 Vesey Street, New York,
New York 10281-8098, and Cantor Fitzgerald&nbsp;&amp; Co., 499 Park Avenue, New York, New York 10022, on the date specified by the Representatives
(which shall be within two Business Days after exercise of said option) for the respective accounts of the several Underwriters, against
payment by the several Underwriters through the Representatives of the purchase price thereof to or upon the order of the Company by wire
transfer payable in same-day funds to an account specified by the Company. If settlement for the Option Securities occurs after the Closing
Date, the Company will deliver to the Representatives on the Settlement Date for the Option Securities, and the obligation of the Underwriters
to purchase the Option Securities shall be conditioned upon receipt of, supplemental opinions, certificates and letters confirming as
of such date the opinions, certificates and letters delivered on the Closing Date pursuant to Section&nbsp;5 hereof, and such further
information, certificates and documents as the Representatives may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and the Representatives
shall instruct purchasers of the Pre-Funded Warrants to make payment for the Pre-Funded Warrants on the Closing Date to the Company by
wire transfer of same day funds payable to the account specified by the Company at a purchase price of $9.749 per Pre-Funded Warrant,
in lieu of payment by the Representatives for such Pre-Funded Warrants, and the Company shall deliver such Pre-Funded Warrants to such
purchasers on the Closing Date in definitive form against such payment, in lieu of the Company&rsquo;s obligation to deliver such Pre-Funded
Warrants to the Representatives; provided that the Representatives shall withhold $0.585 per Pre-Funded Warrant with respect to such Pre-Funded
Warrants as an offset against the payment owed by the Representatives to the Company with respect to the Underwritten Securities hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that any purchaser
of the&nbsp;Pre-Funded&nbsp;Warrants fails to make payment to the Company for all or part of the&nbsp;Pre-Funded&nbsp;Warrants on the
Closing Date, the Representatives agree to make a payment to the Company for such&nbsp;Pre-Funded&nbsp;Warrants at a price per&nbsp;Pre-Funded
Warrant equal to $9.164 and the Company agrees to deliver such Pre-Funded Warrants to the Representatives on the Closing Date in definitive
form against such payment; provided, however, that the Representatives may elect, by written notice to the Company, to receive shares
of Common Stock at the purchase price for the Underwritten Shares in lieu of all or a portion of such&nbsp;Pre-Funded&nbsp;Warrants to
be delivered to the Representatives under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">3.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Offering
by Underwriters.</U> It is understood that the several Underwriters propose to offer the Securities for sale to the public as set forth
in the Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">4.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Agreements.</U>
The Company agrees with the several Underwriters that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Prior
to the termination of the offering of the Securities, the Company will not file any amendment of the Registration Statement or supplement
to the Prospectus or any Rule&nbsp;462(b)&nbsp;Registration Statement unless the Company has furnished you a copy for your review prior
to filing and will not file any such proposed amendment or supplement to which you reasonably object. The Company will cause the Prospectus,
properly completed, and any supplement thereto to be filed in a form approved by the Representatives with the Commission pursuant to the
applicable paragraph of Rule&nbsp;424(b)&nbsp;within the time period prescribed and will provide evidence satisfactory to the Representatives
of such timely filing. The Company will promptly advise the Representatives (i)&nbsp;when the Prospectus, any supplement thereto, shall
have been filed (if required) with the Commission pursuant to Rule&nbsp;424(b)&nbsp;or when any Rule&nbsp;462(b)&nbsp;Registration Statement
shall have been filed with the Commission, (ii)&nbsp;when, prior to termination of the offering of the Securities, any amendment to the
Registration Statement shall have been filed or become effective, (iii)&nbsp;of any request by the Commission or its staff for any amendment
of the Registration Statement, or any Rule&nbsp;462(b)&nbsp;Registration Statement, or for any supplement to the Prospectus or for any
additional information, (iv)&nbsp;of the issuance by the Commission of any stop order suspending the effectiveness of the Registration
Statement or of any notice objecting to its use or the institution or threatening of any proceeding for that purpose and (v)&nbsp;of the
receipt by the Company of any notification with respect to the suspension of the qualification of the Securities for sale in any jurisdiction
or the institution or threatening of any proceeding for such purpose. The Company will use its best efforts to prevent the issuance of
any such stop order or the occurrence of any such suspension or objection to the use of the Registration Statement and, upon such issuance,
occurrence or notice of objection, to obtain as soon as possible the withdrawal of such stop order or relief from such occurrence or objection,
including, if necessary, by filing an amendment to the Registration Statement or a new registration statement and using its best efforts
to have such amendment or new registration statement declared effective as soon as practicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If,
at any time prior to the filing of the Prospectus pursuant to Rule&nbsp;424(b), any event or development occurs as a result of which
the Disclosure Package would include an untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made at such time not misleading, the Company will (i)&nbsp;notify
promptly the Representatives so that any use of the Disclosure Package may cease until it is amended or supplemented; (ii)&nbsp;amend
or supplement the Disclosure Package to correct such statement or omission; and (iii)&nbsp;supply any amendment or supplement to you
in such quantities as you may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If,
at any time when a prospectus relating to the Securities is required to be delivered under the Act (including in circumstances where such
requirement may be satisfied pursuant to Rule&nbsp;172) (the &ldquo;Prospectus Delivery Period&rdquo;), any event occurs as a result of
which the Prospectus as then supplemented would include any untrue statement of a material fact or omit to state any material fact necessary
to make the statements therein in the light of the circumstances under which they were made or the circumstances then prevailing not misleading,
or if it shall be necessary to amend the Registration Statement or supplement the Prospectus to comply with the Act or the rules&nbsp;thereunder,
the Company promptly will (i)&nbsp;notify the Representatives of any such event; (ii)&nbsp;prepare and file with the Commission, subject
to the second sentence of paragraph&nbsp;(a)&nbsp;of this Section&nbsp;4, an amendment or supplement which will correct such statement
or omission or effect such compliance; and (iii)&nbsp;supply any supplemented Prospectus to you in such quantities as you may reasonably
request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">During
the Prospectus Delivery Period, the Company will file all documents required to be filed with the Commission pursuant to Sections 13,
14 and 15 of the Exchange Act in the manner and within the time periods required by the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
soon as practicable, the Company will make generally available to its security holders and to the Representatives an earnings statement
or statements of the Company and its Subsidiaries which will satisfy the provisions of Section&nbsp;11(a)&nbsp;of the Act and Rule&nbsp;158.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company will furnish to the Representatives and counsel for the Underwriters, without charge, signed copies of the Registration Statement
(including exhibits thereto) and to each other Underwriter a copy of the Registration Statement (without exhibits thereto) and, so long
as delivery of a prospectus by an Underwriter or dealer may be required by the Act (including in circumstances where such requirement
may be satisfied pursuant to Rule&nbsp;172), as many copies of each Preliminary Prospectus, the Prospectus and each Issuer Free Writing
Prospectus and any supplement thereto as the Representatives may reasonably request. The Company will pay the expenses of printing or
other production of all documents relating to the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company will arrange, if necessary, for the qualification of the Securities for sale under the laws of such jurisdictions as the Representatives
may designate and will maintain such qualifications in effect so long as required for the distribution of the Securities; <U>provided</U>
that in no event shall the Company be obligated to qualify to do business in any jurisdiction where it is not now so qualified or to take
any action that would subject it to service of process in suits, other than those arising out of the offering or sale of the Securities,
in any jurisdiction where it is not now so subject.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company will not, without the prior written consent of the Representatives, offer, sell, contract to sell, pledge, or otherwise dispose
of, (or enter into any transaction which is designed to, or might reasonably be expected to, result in the disposition (whether by actual
disposition or effective economic disposition due to cash settlement or otherwise) by the Company&nbsp;or any controlled affiliate of
the Company) directly or indirectly, including the filing (or participation in the filing) of a registration statement with the Commission
in respect of, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning
of Section&nbsp;16 of the Exchange Act, any other shares of Common Stock or any securities convertible into, or exercisable, or exchangeable
for, shares of Common Stock or shares of any class of capital stock of the Company or any securities convertible into, or exercisable,
or exchangeable for, any of the foregoing; or publicly announce an intention to effect any such transaction, for a period of 90 days after
the date of this Agreement. The foregoing sentence shall not apply to (A)&nbsp;the Securities to be sold hereunder, and the issuance of
Warrant Shares in connection with the exercise of the Pre-Funded Warrants, (B)&nbsp;any shares of Common Stock issued by the Company upon
the exercise of an option or warrant or the conversion of a security outstanding, or as may be contractually obligated to be issued pursuant
to agreements in effect on the date hereof and incorporated by reference in the Registration Statement, the Disclosure Package and the
Prospectus, (C)&nbsp;any shares of Common Stock issued or options to purchase Common Stock granted pursuant to employee benefit plans
of the Company referred to in the Registration Statement, the Disclosure Package and the Prospectus, (D)&nbsp;any shares of Common Stock
issued pursuant to any non-employee director stock plan or dividend reinvestment plan referred to in the Registration Statement, the General
Disclosure Package and the Prospectus, (E)&nbsp;the filing of a registration statement on Form&nbsp;S-8 or other appropriate forms, and
any amendments thereto, as required by the Act, relating to the Common Stock or other equity-based securities issuable pursuant to the
Company&rsquo;s equity or other incentive plans or employee stock purchase plans referred to in the Registration Statement, the Disclosure
Package and the Prospectus, (F)&nbsp;the filing of any resale registration statement which the Company may be contractually obligated
to file pursuant to agreements in effect on the date hereof and incorporated by reference in the Registration Statement and (G)&nbsp;in
connection with the acquisition by the Company or any of its Subsidiaries of the securities, business, technology, property or other assets
of another person or entity of which the Representatives have been advised in writing, or provided that the aggregate number of shares
of Common Stock that the company may issue or sell pursuant to this clause (G)&nbsp;shall not exceed 5% of the total number of shares
of Common Stock outstanding immediately following the completion of the transactions contemplated by this Agreement and provided, further,
that the recipient of shares of Common Stock shall execute and deliver to the Representatives a lockup letter as described in Section&nbsp;5(m).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
the Representatives, in their sole discretion, agree to release or waive the restrictions set forth in a lock-up letter described in Section&nbsp;5(m)&nbsp;hereof
for an officer or director of the Company and provide the Company with notice of the impending release or waiver at least three Business
Days before the effective date of the release or waiver, the Company agrees to announce the impending release or waiver by a press release
substantially in the form of Exhibit&nbsp;B hereto through a major news service at least two Business Days before the effective date of
the release or waiver.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company will not take, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to
cause or result in, under the Exchange Act or otherwise, stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Securities or the Warrant Shares or to result in a violation of Regulation M.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company agrees to pay the costs and expenses relating to the following matters: (i)&nbsp;the preparation, printing or reproduction and
filing with the Commission of the Registration Statement (including financial statements and exhibits thereto), each Preliminary Prospectus,
the Prospectus and each Issuer Free Writing Prospectus, and each amendment or supplement to any of them; (ii)&nbsp;the printing (or reproduction)
and delivery (including postage, air freight charges and charges for counting and packaging) of such copies of the Registration Statement,
each Preliminary Prospectus, the Prospectus and each Issuer Free Writing Prospectus, and all amendments or supplements to any of them,
as may, in each case, be reasonably requested for use in connection with the offering and sale of the Securities; (iii)&nbsp;the preparation,
printing, authentication, issuance and delivery of certificates for the Securities and the Warrant Shares, including any stamp or transfer
taxes in connection with the original issuance and sale of the Securities and the Warrant Shares; (iv)&nbsp;the printing (or reproduction)
and delivery of this Agreement, any blue sky memorandum and all other agreements or documents printed (or reproduced) and delivered in
connection with the offering of the Securities; (v)&nbsp;the registration of the Securities under the Exchange Act and the listing of
the Shares and the Warrant Shares on the Nasdaq Capital Market; (vi)&nbsp;any registration or qualification of the Securities for offer
and sale under the securities or blue sky laws of the several states (including filing fees and the reasonable fees and expenses of counsel
for the Underwriters relating to such registration and qualification); (vii)&nbsp;any filings required to be made with the Financial Industry
Regulatory Authority,&nbsp;Inc. (&ldquo;<U>FINRA</U>&rdquo;) (including filing fees and the reasonable fees and expenses of counsel for
the Underwriters relating to such filings); (viii)&nbsp;the transportation and other expenses incurred by or on behalf of Company representatives
in connection with presentations to prospective purchasers of the Securities, including, without limitation, expenses associated with
the preparation or dissemination of any electronic roadshow, expenses associated with the production of roadshow slides and graphics and
travel and lodging expenses of Company representatives; (ix)&nbsp;the fees and expenses of the Company&rsquo;s accountants and the fees
and expenses of counsel (including local and special counsel) for the Company; and (x)&nbsp;all other costs and expenses incident to the
performance by the Company of its obligations hereunder; <U>provided</U>, <U>however</U>, that the reasonable fees and expenses of counsel
for the Underwriters incurred pursuant to clauses (vi)&nbsp;and (vii)&nbsp;of this Section&nbsp;4(k)&nbsp;shall not exceed $15,000 in
the aggregate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company agrees that, unless it has or shall have obtained the prior written consent of the Representatives, and each Underwriter, severally
and not jointly, agrees with the Company that, unless it has or shall have obtained, as the case may be, the prior written consent of
the Company, it has not made and will not make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus
or that would otherwise constitute a &ldquo;free writing prospectus&rdquo; (as defined in Rule&nbsp;405) required to be filed by the Company
with the Commission or retained by the Company under Rule&nbsp;433; <U>provided</U> that the prior written consent of the parties hereto
shall be deemed to have been given in respect of the Free Writing Prospectuses included in Schedule II hereto and any electronic roadshow.
Any such free writing prospectus consented to by the Representatives or the Company is hereinafter referred to as a &ldquo;<U>Permitted
Free Writing Prospectus</U>.&rdquo; The Company agrees that (x)&nbsp;it has treated and will treat, as the case may be, each Permitted
Free Writing Prospectus as an Issuer Free Writing Prospectus and (y)&nbsp;it has complied and will comply, as the case may be, with the
requirements of Rules&nbsp;164 and 433 applicable to any Permitted Free Writing Prospectus, including in respect of timely filing with
the Commission, legending and record keeping.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company will comply with all applicable securities and other applicable laws, rules&nbsp;and regulations, including, without limitation,
the Sarbanes-Oxley Act, and will use its reasonable best efforts to cause the Company&rsquo;s directors and officers, in their capacities
as such, to comply with such laws, rules&nbsp;and regulations, including, without limitation, the provisions of the Sarbanes-Oxley Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company will use the net proceeds received by the Company from the sale of the Securities by it in the manner specified in the Preliminary
Prospectus and Prospectus under the caption &ldquo;Use of Proceeds.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall, for a period of one year from the Closing Date, use its commercially reasonable efforts to maintain a registration statement
covering the Warrant Shares issuable upon exercise of the Pre-Funded Warrants, such that the Warrant Shares, when issued, will not be
subject to resale restrictions under the Act except to the extent that the holder thereof is an affiliate of the Company. The Company
shall, at all times while any Pre-Funded Warrants are outstanding, reserve and keep available out of the aggregate of its authorized but
unissued and otherwise unreserved shares of Common Stock, solely for the purpose of enabling it to issue Warrant Shares upon exercise
of such&nbsp;Pre-Funded&nbsp;Warrants, the number of Warrant Shares that are initially issuable and deliverable upon the exercise of the
then-outstanding&nbsp;Pre-Funded&nbsp;Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">5.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Conditions
to the Obligations of the Underwriters.</U> The obligations of the Underwriters to purchase the Underwritten Securities and the Option
Securities, as the case may be, shall be subject to the accuracy of the representations and warranties on the part of the Company contained
herein as of the Execution Time, the Closing Date and any Settlement Date, to the accuracy of the statements of the Company made in any
certificates pursuant to the provisions hereof, to the performance by the Company of its obligations hereunder and to the following additional
conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Prospectus, and any supplement thereto, have been filed in the manner and within the time period required by Rule&nbsp;424(b); any material
required to be filed by the Company pursuant to Rule&nbsp;433(d)&nbsp;under the Act shall have been filed with the Commission within the
applicable time periods prescribed for such filings by Rule&nbsp;433; and no stop order suspending the effectiveness of the Registration
Statement or any notice objecting to its use shall have been issued and no proceedings for that purpose shall have been instituted or
threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall have requested and caused Ropes&nbsp;&amp; Gray LLP, counsel for the Company, to have furnished to the Representatives their
opinion, dated the Closing Date and addressed to the Representatives, in form and substance reasonably satisfactory to the Representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall have requested and caused Goodwin Procter LLP, as counsel for the Company with respect to intellectual property matters,
to have furnished to the Representatives their opinion, dated the Closing Date and addressed to the Representatives, in form and substance
reasonably satisfactory to the Representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Representatives shall have received from Covington&nbsp;&amp; Burling LLP, counsel for the Underwriters, such opinion, dated the Closing
Date and addressed to the Representatives, with respect to the issuance and sale of the Securities, the Registration Statement, the Disclosure
Package, the Prospectus (together with any supplement thereto) and other related matters as the Representatives may reasonably require,
and the Company shall have furnished to such counsel such documents as they request for the purpose of enabling them to pass upon such
matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Split-Segment; Name: 2 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall have furnished to the Representatives a certificate of the Company, signed by the principal executive officer and the principal
financial or accounting officer of the Company, dated the Closing Date, to the effect that the signers of such certificate have carefully
examined the Registration Statement, the Disclosure Package, the Prospectus and any amendment or supplement thereto, and this Agreement
and that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
representations and warranties of the Company in this Agreement are true and correct on and as of the Closing Date with the same effect
as if made on the Closing Date and the Company has complied with all the agreements and satisfied all the conditions on its part to be
performed or satisfied at or prior to the Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
Registration Statement has become effective under the Act and no stop order suspending the effectiveness of the Registration Statement
or any notice objecting to its use has been issued and no proceedings for that purpose have been instituted or, to the Company&rsquo;s
knowledge, threatened; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">since
the date of the most recent financial statements included or incorporated by reference in the Disclosure Package and the Prospectus (exclusive
of any supplement thereto), there has been no material adverse effect on the condition (financial or otherwise), prospects, earnings,
business, prospectus or properties of the Company and its Subsidiaries, taken as a whole, whether or not arising from transactions in
the ordinary course of business, except as set forth in or contemplated in the Disclosure Package and the Prospectus (exclusive of any
supplement thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall have requested and caused&nbsp;Ernst&nbsp;&amp; Young LLP to have furnished to the Representatives, at the Execution Time
and at the Closing Date, letters, dated respectively as of the Execution Time and as of the Closing Date, in form and substance satisfactory
to the Representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall have furnished to the Representatives, at the Execution Time and at the Closing Date, certificates of the Company dated
respectively as of the Execution Time and as of the Closing Date, with respect to certain financial data, signed by the principal financial
or accounting officer of the Company, in form and substance satisfactory to the Representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Subsequent
to the Execution Time or, if earlier, the dates as of which information is given in the Registration Statement (exclusive of any amendment
thereof) and the Prospectus (exclusive of any amendment or supplement thereto), there shall not have been (i)&nbsp;any change or decrease
specified in the letter or letters referred to in paragraph&nbsp;(e)&nbsp;of this Section&nbsp;5 or (ii)&nbsp;any change, or any development
involving a prospective change, in or affecting the condition (financial or otherwise), earnings, business or properties of the Company
and its Subsidiaries taken as a whole, whether or not arising from transactions in the ordinary course of business, except as set forth
in or contemplated in the Disclosure Package and the Prospectus (exclusive of any supplement thereto) the effect of which, in any case
referred to in clause&nbsp;(i)&nbsp;or (ii)&nbsp;above, is, in the sole judgment of the Representatives, so material and adverse as to
make it impractical or inadvisable to proceed with the offering or delivery of the Securities as contemplated by the Registration Statement
(exclusive of any amendment thereof), the Disclosure Package and the Prospectus (exclusive of any amendment or supplement thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Prior
to the Closing Date, the Company shall have furnished to the Representatives such further information, certificates and documents as the
Representatives may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Subsequent
to the Execution Time, there shall not have been any decrease in the rating of any of the Company&rsquo;s debt securities by any &ldquo;nationally
recognized statistical rating organization&rdquo; (as defined for purposes of Rule&nbsp;3(a)(62) under the Exchange Act) or any notice
given of any intended or potential decrease in any such rating or of a possible change in any such rating that does not indicate the direction
of the possible change.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall use its best efforts to cause the Shares to be listed on the Nasdaq Capital Market and to maintain such listing on the Nasdaq
Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
FINRA, upon review, if any, of the terms of the public offering of the Securities, shall not have objected to such offering, such terms
or the Underwriters&rsquo; participation in same.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Prior
to the Execution Time, the Company shall have furnished to the Representatives a letter substantially in the form of Exhibit&nbsp;A hereto
(the &ldquo;<U>Lock-Up Agreement</U>&rdquo;) from each officer and director of the Company listed on Schedule V hereto addressed to the
Representatives. The Company will use its best efforts to enforce the terms of each Lock-Up Agreement and will issue stop-transfer instructions
to the transfer agent for the Common Stock with respect to any transaction or contemplated transaction that would constitute a breach
of or default under the applicable Lock-Up Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall not have received an objection from the Nasdaq Capital Market with respect to the listing of additional shares notification
that it filed with the Nasdaq Capital Market in connection with the Shares and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any of the conditions specified
in this Section&nbsp;5 shall not have been fulfilled when and as provided in this Agreement, or if any of the opinions and certificates
mentioned above or elsewhere in this Agreement shall not be reasonably satisfactory in form and substance to the Representatives and counsel
for the Underwriters, this Agreement and all obligations of the Underwriters hereunder may be canceled at, or at any time prior to, the
Closing Date by the Representatives. Notice of such cancellation shall be given to the Company in writing or by telephone or facsimile
confirmed in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The documents required to
be delivered by this Section&nbsp;5 shall be delivered at the office of Covington&nbsp;&amp; Burling, LLP, counsel for the Underwriters,
at The New York Times Building, 620 Eighth Avenue, New York, NY 10018 (or such other place as mutually may be agreed upon), on or before
the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">6.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Reimbursement
of Underwriters&rsquo; Expenses.</U> If the sale of the Securities provided for herein is not consummated because any condition to the
obligations of the Underwriters set forth in Section&nbsp;5 hereof is not satisfied, because of any termination pursuant to Section&nbsp;10
hereof or because of any refusal, inability or failure on the part of the Company to perform any agreement herein or comply with any provision
hereof other than by reason of a default by any of the Underwriters, the Company will reimburse the Underwriters severally through RBC
Capital Markets, LLC on demand for all expenses (including reasonable fees and disbursements of counsel) that shall have been incurred
by them in connection with the proposed purchase and sale of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">7.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Indemnification
and Contribution.</U> (a)&nbsp; The Company agrees to indemnify and hold harmless each Underwriter, the directors, officers, employees
and agents of each Underwriter and each person who controls any Underwriter within the meaning of either the Act or the Exchange Act against
any and all losses, claims, damages or liabilities, joint or several, to which they or any of them may become subject under the Act, the
Exchange Act or other Federal or state statutory law or regulation, at common law or otherwise, insofar as such losses, claims, damages
or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of a material
fact contained in the Registration Statement as originally filed or in any amendment thereof, or in any Preliminary Prospectus, or the
Prospectus, or any Issuer Free Writing Prospectus, any roadshow used in connection with the offering of the Securities or in any amendment
thereof or supplement thereto or arise out of or are based upon the omission or alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein not misleading, and agrees to reimburse each such indemnified party,
as incurred, for any documented legal or other expenses reasonably incurred by them in connection with investigating or defending any
such loss, claim, damage, liability or action; <U>provided</U>, <U>however</U>, that the Company will not be liable in any such case to
the extent that any such loss, claim, damage or liability arises out of or is based upon any such untrue statement or alleged untrue statement
or omission or alleged omission made therein in reliance upon and in conformity with written information furnished to the Company by or
on behalf of any Underwriter through the Representatives specifically for inclusion therein. This indemnity agreement will be in addition
to any liability which the Company may otherwise have.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
Underwriter severally and not jointly agrees to indemnify and hold harmless the Company, each of its directors, each of its officers who
signs the Registration Statement, and each person who controls the Company within the meaning of either the Act or the Exchange Act, to
the same extent as the foregoing indemnity from the Company to each Underwriter, but only with reference to written information relating
to such Underwriter furnished to the Company by or on behalf of such Underwriter through the Representatives specifically for inclusion
in the documents referred to in the foregoing indemnity. This indemnity agreement will be in addition to any liability which any Underwriter
may otherwise have. The Company acknowledges that the following statements set forth in the Preliminary Prospectus and the Prospectus
under the heading &ldquo;Underwriting&rdquo;: (i)&nbsp;the third paragraph thereof related to selling concessions and (ii)&nbsp;the first
and second paragraphs thereof under the subheading &ldquo;Price Stabilization, Short Positions and Penalty Bids&rdquo; related to stabilization,
syndicate covering transactions and penalty bids, constitute the only information furnished in writing by or on behalf of the several
Underwriters for inclusion in the Preliminary Prospectus, the Prospectus or any Issuer Free Writing Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Promptly
after receipt by an indemnified party under this Section&nbsp;7 of notice of the commencement of any action, such indemnified party will,
if a claim in respect thereof is to be made against an indemnifying party under subsection (a)&nbsp;or (b)&nbsp;above, notify the indemnifying
party of the commencement thereof; but the failure to notify the indemnifying party shall not relieve it from any liability that it may
have under subsection (a)&nbsp;or (b)&nbsp;above except to the extent that it has been materially prejudiced (through the forfeiture of
substantive rights or defenses) by such failure; and provided further that the failure to notify the indemnifying party shall not relieve
it from any liability that it may have to an indemnified party otherwise than under subsection (a)&nbsp;or (b)&nbsp;above. In the case
of parties indemnified pursuant to Section&nbsp;7(a)&nbsp;above, counsel to the indemnified parties shall be selected by the Representatives,
and, in the case of parties indemnified pursuant to Section&nbsp;7(b)&nbsp;above, counsel to the indemnified parties shall be selected
by the Company. An indemnifying party may participate at its own expense in the defense of any such action; provided, however, that counsel
to the indemnifying party shall not (except with the consent of the indemnified party) also be counsel to the indemnified party. In no
event shall the indemnifying parties be liable for fees and expenses of more than one counsel (in addition to any relevant local counsel)
separate from their own counsel for all indemnified parties in connection with any one action or separate but similar or related actions
in the same jurisdiction arising out of the same general allegations or circumstances. No indemnifying party shall, without the prior
written consent of the indemnified party, effect any settlement of any pending or threatened action in respect of which any indemnified
party is or could have been a party and indemnity could have been sought hereunder by such indemnified party unless such settlement (i)&nbsp;includes
an unconditional release of such indemnified party from all liability on any claims that are the subject matter of such action and (ii)&nbsp;does
not include a statement as to, or an admission of, fault, culpability or a failure to act by or on behalf of an indemnified party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of
counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by Section&nbsp;7(a)&nbsp;hereof
effected without its written consent if (i)&nbsp;such settlement is entered into more than 60 days after receipt by such indemnifying
party of the aforesaid request, (ii)&nbsp;such indemnifying party shall have received notice of the terms of such settlement at least
30 days prior to such settlement being entered into and (iii)&nbsp;such indemnifying party shall not have reimbursed such indemnified
party in accordance with such request prior to the date of such settlement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event that the indemnity provided in paragraph&nbsp;(a), (b)&nbsp;or (c)&nbsp;of this Section&nbsp;7 is unavailable to or insufficient
to hold harmless an indemnified party for any reason, the Company and the Underwriters severally agree to contribute to the aggregate
losses, claims, damages and liabilities (including legal or other expenses reasonably incurred in connection with investigating or defending
the same) (collectively &ldquo;<U>Losses</U>&rdquo;) to which the Company and one or more of the Underwriters may be subject in such proportion
as is appropriate to reflect the relative benefits received by the Company on the one hand and by the Underwriters on the other from the
offering of the Securities; <U>provided</U>, <U>however</U>, that in no case shall any Underwriter (except as may be provided in any agreement
among underwriters relating to the offering of the Securities) be responsible for any amount in excess of the underwriting discount or
commission applicable to the Securities purchased by such Underwriter hereunder. If the allocation provided by the immediately preceding
sentence is unavailable for any reason, the Company and the Underwriters severally shall contribute in such proportion as is appropriate
to reflect not only such relative benefits but also the relative fault of the Company on the one hand and of the Underwriters on the other
in connection with the statements or omissions which resulted in such Losses as well as any other relevant equitable considerations. Benefits
received by the Company shall be deemed to be equal to the total net proceeds from the offering (before deducting expenses) received by
it, and benefits received by the Underwriters shall be deemed to be equal to the total underwriting discounts and commissions, in each
case as set forth on the cover page&nbsp;of the Prospectus. Relative fault shall be determined by reference to, among other things, whether
any untrue or any alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to
information provided by the Company on the one hand or by the Underwriters on the other, the intent of the parties and their relative
knowledge, access to information and opportunity to correct or prevent such untrue statement or omission. The Company and the Underwriters
agree that it would not be just and equitable if contribution were determined by pro rata allocation or any other method of allocation
which does not take account of the equitable considerations referred to above. Notwithstanding the provisions of this paragraph&nbsp;(d),
no person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)&nbsp;of the Act) shall be entitled to contribution
from any person who was not guilty of such fraudulent misrepresentation. For purposes of this Section&nbsp;7, each person who controls
an Underwriter within the meaning of either the Act or the Exchange Act and each director, officer, employee and agent of an Underwriter
shall have the same rights to contribution as such Underwriter, and each person who controls the Company within the meaning of either
the Act or the Exchange Act, each officer of the Company who shall have signed the Registration Statement and each director of the Company
shall have the same rights to contribution as the Company, subject in each case to the applicable terms and conditions of this paragraph&nbsp;(e).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">8.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Default
by an Underwriter.</U> If any one or more Underwriters shall fail to purchase and pay for any of the Securities agreed to be purchased
by such Underwriter or Underwriters hereunder and such failure to purchase shall constitute a default in the performance of its or their
obligations under this Agreement, the remaining Underwriters shall be obligated severally to take up and pay for (in the respective proportions
which the amount of Underwritten Shares set forth opposite their names in Schedule&nbsp;I hereto bears to the aggregate amount of Underwritten
Shares set forth opposite the names of all the remaining Underwriters) the Securities which the defaulting Underwriter or Underwriters
agreed but failed to purchase; <U>provided</U>, <U>however</U>, that in the event that the aggregate amount of Securities which the defaulting
Underwriter or Underwriters agreed but failed to purchase shall exceed 10% of the aggregate amount of Underwritten Shares set forth in
Schedule&nbsp;I hereto, the remaining Underwriters shall have the right to purchase all, but shall not be under any obligation to purchase
any, of the Securities, and if such nondefaulting Underwriters do not purchase all the Securities, this Agreement will terminate without
liability to any nondefaulting Underwriter or the Company. In the event of a default by any Underwriter as set forth in this Section&nbsp;8,
the Closing Date shall be postponed for such period, not exceeding five Business Days, as the Representatives shall determine in order
that the required changes in the Registration Statement and the Prospectus or in any other documents or arrangements may be effected.
Nothing contained in this Agreement shall relieve any defaulting Underwriter of its liability, if any, to the Company and any nondefaulting
Underwriter for damages occasioned by its default hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">9.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Recognition
of the U.S. Special Resolution Regimes.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer
from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent
as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were
governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under
a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to
be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement
were governed by the laws of the United States or a state of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
used in this section:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;BHC Act Affiliate&rdquo; has the
meaning assigned to the term &ldquo;affiliate&rdquo; in, and shall be interpreted in accordance with, 12 U.S.C. &sect; 1841(k).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;Covered Entity&rdquo; means any
of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(i)&nbsp;a &ldquo;covered entity&rdquo; as that
term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 252.82(b);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(ii)&nbsp;a &ldquo;covered bank&rdquo; as that
term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 47.3(b); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(iii)&nbsp;a &ldquo;covered FSI&rdquo; as that
term is defined in, and interpreted in accordance with, 12 C.F.R. &sect; 382.2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;Default Right&rdquo; has the meaning
assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &sect;&sect; 252.81, 47.2 or 382.1, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;U.S. Special Resolution Regime&rdquo;
means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank
Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">10.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Termination.</U>
This Agreement shall be subject to termination in the absolute discretion of the Representatives, by notice given to the Company prior
to delivery of and payment for the Securities, if at any time prior to such delivery and payment (i)&nbsp;trading in the Company&rsquo;s
Common Stock shall have been suspended by the Commission or the Nasdaq Capital Market or trading in securities generally on the New York
Stock Exchange or Nasdaq shall have been suspended or limited or minimum prices shall have been established on either of such exchanges,
(ii)&nbsp;a banking moratorium shall have been declared either by U.S. Federal or New York State authorities or (iii)&nbsp;there shall
have occurred any outbreak or escalation of hostilities, declaration by the United States of a national emergency or war, or other calamity
or crisis the effect of which on financial markets is such as to make it, in the sole judgment of the Representatives, impractical or
inadvisable to proceed with the offering or delivery of the Securities as contemplated by the Preliminary Prospectus or the Prospectus
(exclusive of any supplement thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">11.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Representations
and Indemnities to Survive.</U> The respective agreements, representations, warranties, indemnities and other statements of the Company
or its officers and of the Underwriters set forth in or made pursuant to this Agreement will remain in full force and effect, regardless
of any investigation made by or on behalf of any Underwriter or the Company or any of the officers, directors, employees, agents or controlling
persons referred to in Section&nbsp;7 hereof, and will survive delivery of and payment for the Securities. The provisions of Sections&nbsp;6
and 7 hereof shall survive the termination or cancellation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">12.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Notices.</U>
All communications hereunder will be in writing and effective only on receipt, and, if sent to the Representatives, will be mailed, delivered
or telefaxed to RBC Capital Markets, LLC, 200 Vesey Street, 8<SUP>th</SUP> Floor, New York, New York 10281-8098, Attention: Equity Capital
Markets, Fax: (212) 428-6260 and to Cantor Fitzgerald&nbsp;&amp; Co., 499 Park Avenue, New York, New York 10022, Attention: Capital Markets,
Fax: (212) 307-3730; or, if sent to the Company, will be mailed or delivered to Verastem,&nbsp;Inc., 117 Kendrick Street, Suite&nbsp;500,
Needham, Massachusetts 02494, or via email to dcalkins@verastem.com, with a copy to Ropes&nbsp;&amp; Gray LLP, Prudential Tower, 800 Boylston
Street, Boston, MA 02199, Attention: Thomas Danielski, email: Thomas.Danielski@ropesgray.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">13.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Successors.</U>
This Agreement will inure to the benefit of and be binding upon the parties hereto and their respective successors and the officers, directors,
employees, agents and controlling persons referred to in Section&nbsp;7 hereof, and no other person will have any right or obligation
hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">14.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>No
Fiduciary Duty</U>. The Company hereby acknowledges that (a)&nbsp;the purchase and sale of the Securities pursuant to this Agreement is
an arm&rsquo;s-length commercial transaction between the Company, on the one hand, and the Underwriters and any affiliate through which
it may be acting, on the other, (b)&nbsp;the Underwriters are acting as principal and not as an agent or fiduciary of the Company, any
of its Subsidiaries or their respective stockholders, creditors, employees or any other party and (c)&nbsp;the Company&rsquo;s engagement
of the Underwriters in connection with the offering and the process leading up to the offering is as independent contractors and not in
any other capacity. Furthermore, the Company agrees that it is solely responsible for making its own judgments in connection with the
offering (irrespective of whether any of the Underwriters has advised or is currently advising the Company on related or other matters).
The Company agrees that it will not claim that the Underwriters have rendered advisory services of any nature or respect, or owe an agency,
fiduciary or similar duty to the Company, in connection with such transaction or the process leading thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">15.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Integration</U>.
This Agreement supersedes all prior agreements and understandings (whether written or oral) between the Company and the Underwriters,
or any of them, with respect to the subject matter hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">16.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Applicable
Law.</U> This Agreement and any claim, controversy or dispute arising under or related to this Agreement or the transactions contemplated
hereby (including without limitation, any claims sounding in equity, statutory law, contract law or tort law arising out of the subject
matter hereof) shall be governed by and construed in accordance with the laws of the State of New York, without giving effect to its conflicts
of laws doctrine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">17.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Waiver
of Jury Trial</U>. The Company hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial
by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">18.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Counterparts</U>.
This Agreement may be signed in one or more counterparts, each of which shall constitute an original and all of which together shall constitute
one and the same agreement. Electronic signatures complying with the New York Electronic Signatures and Records Act (N.Y. State Tech.
 &sect;&sect;301-309), as amended from time to time, the U.S. federal ESIGN Act of 2000, or other applicable law will be deemed original
signatures for purposes of this Agreement. Transmission by telecopy, electronic mail or other transmission method of an executed counterpart
of this Agreement will constitute due and sufficient delivery of such counterpart.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">19.</FONT><FONT STYLE="text-transform: uppercase">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt"><U>Headings.</U>
The section headings used herein are for convenience only and shall not affect the construction hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing is in accordance
with your understanding of our agreement, please sign and return to us the enclosed duplicate hereof, whereupon this letter and your acceptance
shall represent a binding agreement among the Company and the several Underwriters.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Very truly yours,</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Verastem,&nbsp;Inc.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"> /s/ Brian M. Stuglik</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Name: Brian M. Stuglik</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Title: Chief Executive Officer</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">The foregoing Agreement is hereby <BR>
confirmed and accepted as of the <BR>
date first above written.</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">RBC Capital Markets, LLC</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">Cantor Fitzgerald&nbsp;&amp; Co.</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">By:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 47%">RBC Capital Markets, LLC</TD>
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Richard Hsieh</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name: Richard Hsieh</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title: Managing Director</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Cantor Fitzgerald&nbsp;&amp; Co.</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">/s/ Sage Kelly</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name: Sage Kelly</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title: Global Head of Investment Banking</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">For themselves and the other<BR>
 several Underwriters named in <BR>
Schedule I to the foregoing Agreement.</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Schedule&nbsp;I</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">Underwriters</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of <BR> Underwritten <BR> Shares<BR> to be Purchased</FONT></TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Pre-Funded <BR> Warrants<BR> to be Purchased</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 74%; text-align: justify">RBC Capital Markets, LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">3,052,099</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">653,901</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">Cantor Fitzgerald&nbsp;&amp; Co.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,693,028</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">576,972</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">BTIG, LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">646,326</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">138,473</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">H.C. Wainwright&nbsp;&amp; Co., LLC</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">502,699</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">107,701</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: justify">A.G.P./Alliance Global Partners</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">287,257</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">61,544</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt; padding-left: 0.125in">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,181,409</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,538,591</TD><TD STYLE="padding-bottom: 2.5pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Schedule&nbsp;II</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Schedule of Issuer Free Writing Prospectuses included in the Disclosure
Package: None.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Schedule&nbsp;III</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Pricing Terms:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>The Company is selling 7,181,409 shares of Common Stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>The Company is selling 1,538,591 Pre-Funded Warrants.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">The Company has granted an option to the Underwriters to purchase up to an additional 1,308,000 shares of Common Stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD>The public offering price per share of Common Stock is $9.75.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">5.</TD><TD>The public offering price per Pre-Funded Warrant is $9.749.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Schedule&nbsp;IV</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Schedule of Significant Subsidiaries:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Verastem Europe GmbH</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Verastem Securities Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Schedule V</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Schedule of Directors, Officers and Stockholders
Subject to Lock-Up:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Paul Bunn</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Daniel Calkins</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Robert Gagnon</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Anil Kapur</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Michael Kauffman</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">John Johnson</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Daniel Paterson</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Michelle Robertson</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Eric Rowinsky</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Brian Stuglik</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Karin Tollefson</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&nbsp;A &ndash; Form&nbsp;of Lock-Up
Agreement</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.75in; text-align: right; text-indent: -0.25in">[&#9679;], 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RBC Capital Markets, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Cantor Fitzgerald&nbsp;&amp; Co.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As Representatives of the several Underwriters,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o RBC Capital Markets, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brookfield Place<BR>
200 Vesey Street<BR>
New York, New York 10281-8098</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">c/o Cantor Fitzgerald&nbsp;&amp; Co.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">499 Park Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This letter agreement is being delivered to you
in connection with the proposed Underwriting Agreement (the &ldquo;Underwriting Agreement&rdquo;), between Verastem,&nbsp;Inc., a Delaware
corporation (the &ldquo;Company&rdquo;), and each of RBC Capital Markets, LLC and Cantor Fitzgerald&nbsp;&amp; Co. (the &ldquo;Representatives&rdquo;)
as representatives of a group of Underwriters named therein, relating to an underwritten public offering of [common stock, $0.0001 par
value per share (the &ldquo;Common Stock&rdquo;)], of the Company (the &ldquo;Offering&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In order to induce you and the other Underwriters
to enter into the Underwriting Agreement, the undersigned will not, without the prior written consent of the Representatives, offer, sell,
contract to sell, pledge or otherwise dispose of, (or enter into any transaction which is designed to, or might reasonably be expected
to, result in the disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise) by
the undersigned or any affiliate of the undersigned or any person in privity with the undersigned or any affiliate of the undersigned),
directly or indirectly, including the filing (or participation in the filing) of a registration statement (except for the filing of any
resale registration statement which the Company may be contractually obligated to file pursuant to agreements in effect on the date hereof
and incorporated by reference in the Registration Statement, as such term is defined in the Underwriting Agreement) with the Securities
and Exchange Commission (the &ldquo;Commission&rdquo;) in respect of, or establish or increase a put equivalent position or liquidate
or decrease a call equivalent position within the meaning of Section&nbsp;16 of the Securities Exchange Act of 1934, as amended, and the
rules&nbsp;and regulations of the Commission promulgated thereunder (the &ldquo;Exchange Act&rdquo;) with respect to, any shares of capital
stock of the Company or any securities convertible into, or exercisable or exchangeable for such capital stock, or publicly announce an
intention to effect any such transaction, for a period from the date hereof until 90 days after the date of the Underwriting Agreement
(the &ldquo;Restricted Period&rdquo;). The foregoing sentence shall not apply to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&nbsp;transactions relating to shares of Common
Stock or other securities acquired in the Offering or in open market transactions after the completion of the Offering; <I>provided</I>
that no filing under Section&nbsp;16(a)&nbsp;of the Exchange Act shall be required or shall be voluntarily made in connection with subsequent
sales of Common Stock or other securities acquired in such transactions (other than as otherwise permitted pursuant to the other provisions
of this letter agreement);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(b)&nbsp;transfers
to the Company pursuant to a &ldquo;net&rdquo; or &ldquo;cashless&rdquo; exercise by the undersigned of outstanding equity awards pursuant
to an employee benefit plan of the Company as in effect and disclosed in the final prospectus used for the Offering, including to satisfy
the exercise price or withholding tax or remittance obligations; <I>provided</I> that (i)&nbsp;any shares of Common Stock received upon
such exercise shall be subject to all of the restrictions set forth in this letter agreement and (ii)&nbsp;no filing under Section&nbsp;16(a)&nbsp;of
the Exchange Act, reporting a reduction in beneficial ownership of shares of Common Stock, shall be required or shall be voluntarily made
during the Restricted Period, unless such filing indicates in the footnotes thereto </FONT>that the filing relates to the exercise of
equity awards, that no shares were sold to the public by the reporting person and the shares of Common Stock received upon exercise of
such securities are subject to a lock-up agreement with the Underwriters of the Offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(c)&nbsp;the
exercise of options, stock appreciation rights or warrants to purchase shares of Common Stock pursuant to an employee benefit plan disclosed
in the final prospectus used for the Offering; <I>provided</I> that (i)&nbsp;any shares of Common Stock received upon such exercise shall
be subject to all of the restrictions set forth in this letter agreement and (ii)&nbsp;no filing under Section&nbsp;16(a)&nbsp;of the
Exchange Act, reporting a reduction in beneficial ownership of shares of Common Stock, shall be required or shall be voluntarily made
during the Restricted Period, unless such filing shall indicate in the footnotes thereto </FONT>that such filing relates to the exercise
of options, stock appreciation rights or warrants to purchase shares of Common Stock and the shares of Common Stock received upon exercise
of such securities are subject to a lock-up agreement with the Underwriters of the Offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(d)&nbsp;transfers
of shares of Common Stock or any security convertible into Common Stock as a bona fide gift; <I>provided</I> that (i)&nbsp;no filing under
Section&nbsp;16(a)&nbsp;of the Exchange Act, reporting a reduction in beneficial ownership of shares of Common Stock, shall be required
or shall be voluntarily made during the Restricted Period, unless such filing indicates in the footnotes thereto </FONT>that such transfer
was made in connection with a bona fide gift and the shares of Common Stock or securities convertible into Common Stock, as applicable,
received pursuant to the bona fide gift are subject to a lock-up agreement with the Underwriters of the Offering, and (ii)&nbsp;each donee,
distributee or transferee shall sign and deliver a lock-up letter substantially in the form of this letter agreement;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(e)&nbsp;distributions
of shares of Common Stock or any security convertible into Common Stock to partners, limited partners, members, managers, affiliates (within
the meaning set forth in Rule&nbsp;405 under the Securities Act of 1933, as amended, and including the subsidiaries of the undersigned),
stockholders or holders of similar equity interests of the undersigned or to any investment fund or other entity that directly or indirectly
controls or manages, is under common control with, or is controlled or managed by, the undersigned or affiliates of the undersigned (including,
for the avoidance of doubt, where the undersigned is a partnership, to its general partner or a successor partnership or fund, or any
other funds controlled or managed by such partnership) (including upon the liquidation or dissolution of the undersigned pursuant to a
plan of liquidation approved by the undersigned&rsquo;s equity holders) or in the case of a trust, to a grantor or beneficiary of the
trust; <I>provided</I> that (i)&nbsp;each donee, distributee or transferee shall sign and deliver a lock-up letter substantially in the
form of this letter agreement and (ii)&nbsp;no filing under Section&nbsp;16(a)&nbsp;of the Exchange Act, reporting a reduction in beneficial
ownership of shares of Common Stock, shall be required or shall be voluntarily made during the Restricted Period, unless such filing indicates
in the footnotes thereto </FONT>that such transfer is a distribution to limited partners, members, stockholders or holders of similar
equity interests, that no shares of Common Stock or securities convertible into Common Stock, as applicable, were sold to the public by
the reporting person and the shares of Common Stock or securities convertible into Common Stock, as applicable, distributed are subject
to a lock-up agreement with the Underwriters of the Offering;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f)&nbsp;transfers of shares of Common Stock, (i)&nbsp;to
any immediate family member, trusts for the direct or indirect benefit of the undersigned or the immediate family members of the undersigned
or any of their successors upon death, or any partnership or limited liability company, the partners or members of which consist of the
undersigned and/or immediate family members or other dependents of the undersigned, and in each case such transfer does not involve a
disposition for value, or (ii)&nbsp;to a nominee or custodian of a person or entity to whom disposition or transfer would be permitted
under clause (f)(i)&nbsp;above (for purposes of this letter agreement, &ldquo;immediate family&rdquo; means any relationship by blood,
marriage or adoption, not more remote than first cousin); <I>provided</I> that in the case of any transfer pursuant to this clause (f),
(i)&nbsp;each donee, distributee or transferee shall sign and deliver a lock-up letter substantially in the form of this letter agreement
and (ii)&nbsp;no filing by any party (donor, donee, transferor or transferee) under the Exchange Act (other than any required filing on
a Form&nbsp;5 made after the expiration of the Restricted Period or, if a Form&nbsp;5 filing is required to be made prior to the expiration
of the Restricted Period, such Form&nbsp;5 filing is made on the latest date permitted under the Exchange Act) or other public announcement
reporting a reduction in beneficial ownership of Common Stock shall be required or shall be made voluntarily in connection with such transfer
or distribution;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(g)&nbsp;transfers of shares of Common Stock or
any other options or warrants or other rights to acquire Common Stock or any securities exchangeable or exercisable for or convertible
into Common Stock by will or intestacy or pursuant to a domestic order divorce settlement, divorce decree or separation agreement; <I>provided</I>
that in the case of any transfer pursuant to (g), unless prohibited by an order of a court, (i)&nbsp;each donee or distributee shall sign
and deliver a lock-up letter substantially in the form of this letter and (ii)&nbsp;no filing under Section&nbsp;16(a)&nbsp;of the Exchange
Act, reporting a reduction in beneficial ownership of shares of Common Stock, shall be required or shall be voluntarily made during the
Restricted Period, unless such filing indicates in the footnotes thereto the nature of the transfer or disposition;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(h)&nbsp;transfers or dispositions of Common Stock
or any security convertible into or exercisable or exchangeable for Common Stock to the Company (i)&nbsp;pursuant to any contractual arrangement
in effect on the date of this agreement and described in the final prospectus used for the Offering that provides for the repurchase of
the undersigned&rsquo;s Common Stock or other securities by the Company or (ii)&nbsp;in connection with the termination of the undersigned&rsquo;s
employment with or service to the Company; <I>provided</I> that in each case no filing under Section&nbsp;16(a)&nbsp;of the Exchange Act,
reporting a reduction in beneficial ownership of shares of Common Stock, shall be required or shall be voluntarily made during the Restricted
Period, unless such filing indicates in the footnotes thereto the nature of the transfer or disposition;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(i)&nbsp;the establishment of a trading plan pursuant
to Rule&nbsp;10b5-1 under the Exchange Act (a &ldquo;Rule&nbsp;10b5-1 Trading Plan&rdquo;) for the transfer of shares of Common Stock,
<I>provided</I> that (x)&nbsp;such plan does not provide for the transfer of Common Stock during the Restricted Period and (y)&nbsp;no
public announcement or filing under the Exchange Act shall be required or shall be voluntarily made by or on behalf of the undersigned
or the Company during the Restricted Period regarding the establishment of such plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(j)&nbsp;(i)&nbsp;the transfer of shares of Common
Stock or any security convertible into or exercisable or exchangeable for Common Stock pursuant to a bona fide third party tender offer,
merger, consolidation or other similar transaction made to all holders of Common Stock and approved by the Company&rsquo;s board of directors
involving a Change of Control (as defined below) and (ii)&nbsp;entry into any lock-up, voting or similar agreement pursuant to which the
undersigned may agree to transfer, sell, tender or otherwise dispose of Common Stock or such other securities in connection with a transaction
described in (i)&nbsp;above, <I>provided</I>, that in the event that the tender offer, merger, consolidation or other such transaction
is not completed, the undersigned&rsquo;s Common Stock or any security convertible into or exercisable or exchangeable for Common Stock
shall remain subject to the terms of this letter agreement;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(k)&nbsp;transfers
pursuant to an order of a court or regulatory agency; <I>provided</I> that in the case of any transfer pursuant to (k), (i)&nbsp;unless
prohibited by an order of a court or regulatory agency, the undersigned must request that each transferee sign and deliver a lock-up letter
substantially in the form of this letter and (ii)&nbsp;any filing under Section&nbsp;16(a)&nbsp;of the Exchange Act reporting a reduction
in beneficial ownership of shares of Common Stock required to be made during the Restricted Period shall </FONT>state that such transfer
is pursuant to an order of a court or regulatory agency;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(l)&nbsp;transfers
to the Company for the purpose of satisfying any tax or other governmental withholding obligation with respect to, or in connection with,
a vesting event of the Company&rsquo;s securities, upon the exercise of the Company&rsquo;s securities or upon expiration of the Company&rsquo;s
securities, in each case held by the undersigned; <I>provided</I> that no filing under Section&nbsp;16(a)&nbsp;of the Exchange Act, reporting
a reduction in beneficial ownership of shares of Common Stock, shall be required or shall be voluntarily made during the Restricted Period,
unless such filing indicates in the footnotes thereto </FONT>that the shares were transferred to the Company in order to satisfy tax or
other governmental withholding obligations of the reporting person and that no shares were sold to the public by the reporting person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(m)&nbsp;sales of common stock for the purpose
of satisfying any tax or other governmental withholding obligation with respect to, or in connection with, a vesting event of the Company&rsquo;s
securities, upon the exercise of the Company&rsquo;s securities or upon expiration of the Company&rsquo;s securities, in each case held
by the undersigned; provided that no filing under Section&nbsp;16(a)&nbsp;of the Exchange Act, reporting a reduction in beneficial ownership
of shares of Common Stock, shall be required or shall be voluntarily made during the Restricted Period, unless such filing indicates in
the footnotes thereto that the shares were sold in order to satisfy tax or other governmental withholding obligations of the reporting
person; or</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">(n)&nbsp;in
connection with sales of Common Stock made pursuant to a Rule&nbsp;10b5-1 Trading Plan that has been entered into by the undersigned prior
to the date of this letter agreement; <I>provided</I> that (i)&nbsp;such Rule&nbsp;10b5-1 Trading Plan was established by the undersigned
prior to the execution of this letter agreement, the existence and details of such Rule&nbsp;10b5-1 Trading Plan were communicated to
the Underwriters prior to the execution of this letter agreement, (ii)&nbsp;such Rule&nbsp;10b5-1 Trading Plan will not be amended or
otherwise modified during the Restricted Period, and (iii)&nbsp;no filing under Section&nbsp;16(a)&nbsp;of the Exchange Act, reporting
a reduction in beneficial ownership of shares of Common Stock, shall be required or shall be voluntarily made during the Restricted Period,
unless such filing indicates in the footnotes thereto </FONT>that the shares were sold pursuant to such Rule&nbsp;10b5-1 Trading Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For purposes of clause (j)&nbsp;above, &ldquo;Change of Control&rdquo;
means any bona fide third party tender offer, merger, consolidation or other similar transaction, in one transaction or a series of related
transactions, the result of which is that any &ldquo;person&rdquo; (as defined in Section&nbsp;13(d)(3)&nbsp;of the Exchange Act) or group
of persons, other than the Company, becomes the beneficial owner (as defined Rule&nbsp;13d-3 and 13d-5 of the Exchange Act) of more than
50% of total voting power of the voting stock of the Company (or the surviving entity).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Whether or not the Offering actually occurs depends
on a number of factors, including market conditions. Any Offering will only be made pursuant to an Underwriting Agreement, the terms of
which are subject to negotiation between the Company and the Underwriters. The undersigned understands that if (1)&nbsp;the Company withdraws
the registration statement relating to the Offering, (2)&nbsp;the Underwriting Agreement (other than the provisions thereof which survive
termination) shall terminate or be terminated prior to payment for and delivery of the Common Stock to be sold thereunder, (3)&nbsp;the
Representatives, on behalf of the Underwriters, advise the Company, or the Company advises the Representatives, in writing, prior to the
execution of the Underwriting Agreement, that they have determined not to proceed with the Offering or (4)&nbsp;the closing of the Offering
shall not have occurred on or before June&nbsp;30, 2023, the undersigned shall be released from all obligations under this letter agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The undersigned hereby consents to receipt of this
letter agreement in electronic form and understands and agrees that this letter agreement may be signed electronically. In the event that
any signature is delivered by electronic mail, or otherwise by electronic transmission evidencing an intent to sign this letter agreement,
such electronic mail or other electronic submission shall create a valid and binding obligation of the undersigned with the same force
and effect as if such signature were an original. Execution and delivery of this lock-up agreement by electronic mail or other electronic
transmission is legal, valid and binding for all purposes.</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 46%">Yours very truly,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name&nbsp;&nbsp;&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&nbsp;B &ndash; Form&nbsp;of Press
Release</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Verastem,&nbsp;Inc.<BR>
[Date]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Verastem,&nbsp;Inc.</FONT>
(the &ldquo;Company&rdquo;) announced today that RBC Capital Markets, LLC and Cantor Fitzgerald&nbsp;&amp; Co., the joint book-running
managers in the Company&rsquo;s recent public sale of shares of common stock and pre-funded warrants to purchase shares of common stock,
is [waiving] [releasing] a lock-up restriction with respect to [ ] shares of the Company&rsquo;s common stock held by [certain officers
or directors] [an officer or director] of the Company. The [waiver] [release] will take effect on [ ], [ ] 2023, and the shares may be
sold on or after such date.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>This press release is not an offer for sale of the securities in
the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United
States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ADDENDUM &ndash; Form&nbsp;of Waiver of Lock-Up</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Verastem,&nbsp;Inc.<BR>
Public Offering of Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.75in; text-align: right; text-indent: -0.25in">[&#9679;], 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[Name and Address of<BR>
Officer or Director<BR>
Requesting Waiver]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr./Ms.&nbsp;[Name]:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">This letter is being delivered to you in connection
with the offering by Verastem,&nbsp;Inc. (the &ldquo;Company&rdquo;) of [ &nbsp;&nbsp;&nbsp;] shares of common stock, $0.0001 par value per share, of the
Company (the &ldquo;Common Stock&rdquo;) and [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ] pre-funded warrants to purchase shares of Common Stock and the lock-up letter dated [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
], 2023 (the &ldquo;Lock-up Letter&rdquo;), executed by you in connection with such offering, and your request for a [waiver] [release]
dated [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ], 2023, with respect to [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ] shares of Common Stock (the &ldquo;Shares&rdquo;).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">RBC Capital Markets, LLC and Cantor Fitzgerald&nbsp;&amp;
Co. hereby agree to [waive] [release] the transfer restrictions set forth in the Lock-up Letter, but only with respect to the Shares,
effective [ ], 2023; <U>provided</U>, <U>however</U>, that such [waiver] [release] is conditioned on the Company announcing the impending
[waiver] [release] by press release through a major news service at least two business days before effectiveness of such [waiver] [release].
This letter will serve as notice to the Company of the impending [waiver] [release].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except as expressly [waived] [released] hereby,
the Lock-up Letter shall remain in full force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif">Yours very truly,</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">[Signature of RBC Representative]</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">[Name and title of RBC Representative]</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">[Signature of Cantor Representative.]</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">[Name and title of Cantor Representative.]</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">cc: Verastem,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>tm2318315d3_ex4-1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRE-FUNDED WARRANT TO PURCHASE STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Company:</B> Verastem,&nbsp;Inc., a Delaware corporation</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Warrant No.&nbsp;2023-</B>[___]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Number of Shares:</B> [___], subject to adjustment</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Type/Series&nbsp;of Stock:</B> Common Stock, $0.0001 par value
per share</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Issue Date:</B> June&nbsp;21, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt"><B>Expiration Date:</B> The first date
on which no shares of Common Stock are issuable upon an exercise of this Warrant.</FONT><B> <FONT STYLE="font-size: 10pt">See
also Section&nbsp;4.1(b).</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS WARRANT CERTIFIES THAT,
for good and valuable consideration, [___] (together with any successor or permitted assignee or transferee of this warrant to purchase
stock (this &ldquo;<B><U>Warrant</U></B>&rdquo;) or of any shares issued upon exercise hereof, &ldquo;<B><U>Holder</U></B>&rdquo;) is
entitled, at any time on or after the above-referenced Issue Date, to purchase up to the above-stated number of fully paid and non-assessable
shares (the &ldquo;<B><U>Shares</U></B>&rdquo;) of the above-stated Type/Series&nbsp;of Stock (the &ldquo;<B><U>Class</U></B>&rdquo;)
of the above-named company (the &ldquo;<B><U>Company</U></B>&rdquo;) until this Warrant is exercised in full, all as set forth above
and as adjusted pursuant to Section&nbsp;2 of this Warrant, subject to the provisions and upon the terms and conditions set forth in
this Warrant. The aggregate exercise price of this Warrant of $9.75, except for a nominal exercise price of $0.001 per Warrant Share
(as defined below), was paid to the Company on or prior to the date of issuance of this Warrant, and consequently, no additional consideration
(other than the nominal exercise price of $0.001 per Warrant Share) shall be required to be paid by Holder to effect any exercise of
this Warrant. Holder shall not be entitled to return or refund of all, or any portion, of such prepaid aggregate exercise price under
any circumstance or for any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Expiration
Date. The remaining unpaid exercise price per share of Common Stock under this Warrant shall be $0.001, subject to adjustment as provided
herein (the &ldquo;<B><U>Warrant Price</U></B>&rdquo; or &ldquo;<B><U>Exercise Price</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECTION&nbsp;1. <U>EXERCISE</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">1.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Method
of Exercise; Delivery of Warrant Shares</U>. Holder may at any time and from time to time exercise this Warrant, in whole or in part,
by delivering to the Company the original of this Warrant together with a duly executed Notice of Exercise in substantially the form
attached hereto as <U>Appendix 1</U> and, unless Holder is exercising this Warrant pursuant to a cashless exercise set forth in Section&nbsp;1.2,
wire transfer of same-day funds (to an account designated by the Company), or other form of payment acceptable to the Company for the
aggregate Warrant Price for the Shares being purchased (such date of delivery, the &ldquo;<B><U>Exercise Date</U></B>&rdquo;). Notwithstanding
any contrary provision herein, if this Warrant was originally executed and/or delivered electronically, in no event shall Holder be required
to surrender or deliver an ink-signed paper copy of this Warrant in connection with its exercise hereof or of any rights hereunder, nor
shall Holder be required to surrender or deliver a paper or other physical copy of this Warrant in connection with any exercise hereof.
Execution and delivery of the Exercise Notice shall have the same effect as cancellation of the original Warrant and issuance of a new
warrant evidencing the right to purchase the remaining number of Warrant Shares (any such new warrant, a &ldquo;<B><U>New Warrant</U></B>&rdquo;),
which New Warrant shall in all other respects be identical with this Warrant. The Company shall cause the shares underlying the Warrant
(the &ldquo;<B><U>Warrant Shares</U></B>&rdquo;) purchased hereunder to be transmitted by the Transfer Agent to the Holder by the date
that is the earliest of (i)&nbsp;two (2)&nbsp;Trading Days after the delivery to the Company of the Notice of Exercise and (ii)&nbsp;the
number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date,
the &ldquo;<B><U>Warrant Share Delivery Date</U></B>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for
all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the
case of a cashless exercise) is received within the earlier of (i)&nbsp;two (2)&nbsp;Trading Days and (ii)&nbsp;the number of Trading
Days comprising the Standard Settlement Period following delivery of the Notice of Exercise. If the Company fails to cause the Transfer
Agent to transmit to the Holder the Warrant Shares pursuant to this section by the Warrant Share Delivery Date, then the Holder will
have the right to rescind such exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Standard Settlement
Period</U></B>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading
Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Trading Day</U></B>&rdquo;
means a day on which the Common Stock is traded on a Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B><U>Transfer Agent</U></B>&rdquo;
means Computershare Trust Company, N.A., the Company&rsquo;s transfer agent and registrar for the Common Stock, and any successor appointed
in such capacity, or if none, the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">1.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Cashless
Exercise</U>. On any exercise of this Warrant, in lieu of payment of the aggregate Warrant Price in the manner as specified in Section&nbsp;1.1
above, but otherwise in accordance with the requirements of Section&nbsp;1.1, Holder may elect to receive Shares equal to the value of
this Warrant, or portion hereof as to which this Warrant is being exercised. Thereupon, the Company shall issue to the Holder such number
of fully paid and non-assessable Shares as are computed using the following formula:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">X = Y(A-B)/A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">X =</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the
                                            number of Shares to be issued to the Holder;</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">Y =</TD><TD STYLE="text-align: justify">the
                                            number of Shares with respect to which this Warrant is being exercised (inclusive of the
                                            Shares surrendered to the Company in payment of the aggregate Warrant Price);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">A =</TD><TD STYLE="text-align: justify">the
                                            fair market value (as determined pursuant to Section&nbsp;1.3 below) of one Share; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">B =</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">the
                                            Warrant Price.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">1.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Fair
Market Value</U>. If shares of the Class&nbsp;are then traded or quoted on a nationally recognized securities exchange, inter-dealer
quotation system or over-the-counter market (a &ldquo;<B><U>Trading Market</U></B>&rdquo;), the fair market value of a Share shall be
the closing price or last sale price of a share of the Class&nbsp;reported for the Business Day (as defined below) immediately before
the date on which Holder delivers this Warrant together with its Notice of Exercise to the Company. If shares of the Class&nbsp;are not
then traded in a Trading Market, the Board of Directors of the Company shall determine the fair market value of a Share in its reasonable
good faith judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">1.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Delivery
of New Warrant</U>. Within a reasonable time after Holder exercises this Warrant in the manner set forth in Section&nbsp;1.1 or 1.2 above,
if this Warrant has not been fully exercised and has not expired, the Company shall deliver to Holder a New Warrant of like tenor representing
the Shares not so acquired, which may be delivered electronically.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">1.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Replacement
of Warrant</U>. On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant
and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form, substance and
amount to the Company or, in the case of mutilation, on surrender of this Warrant to the Company for cancellation, the Company shall,
within a reasonable time, execute and deliver to Holder, in lieu of this Warrant, a new warrant of like tenor and amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">1.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Treatment
of Warrant Upon Acquisition of Company</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Acquisition</U>.
For the purpose of this Warrant, &ldquo;<B><U>Acquisition</U></B>&rdquo; means any transaction or series of related transactions involving:
(i)&nbsp;the sale, lease, exclusive license, or other disposition of all or substantially all of the assets of the Company; (ii)&nbsp;any
merger or consolidation of the Company into or with another person or entity (other than a merger or consolidation effected exclusively
to change the Company&rsquo;s domicile), or any other corporate reorganization, in which the stockholders of the Company in their capacity
as such immediately prior to such merger, consolidation or reorganization, own less than a majority of the Company&rsquo;s (or the surviving
or successor entity&rsquo;s) outstanding voting power immediately after such merger, consolidation or reorganization (or, if such Company
stockholders beneficially own a majority of the outstanding voting power of the surviving or successor entity as of immediately after
such merger, consolidation or reorganization, such surviving or successor entity is not the Company); or (iii)&nbsp;any sale or other
transfer by the stockholders of the Company of shares representing at least a majority of the Company&rsquo;s then-total outstanding
combined voting power.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Treatment
of Warrant at Acquisition</U>. In the event of an Acquisition and if Holder has not exercised this Warrant pursuant to Section&nbsp;1
above as to all Shares, then, following such Acquisition, the Holder shall receive upon exercise hereof the kind and amount of securities,
cash or other property which the Holder would have been entitled to receive (the &ldquo;<B><U>Alternate Consideration</U></B>&rdquo;)
pursuant to such Acquisition if such exercise had taken place immediately prior to such Acquisition. In any such case, appropriate adjustment
(as reasonably determined in good faith by the Board of Directors of the Company) shall be made in the application of the provisions
set forth herein with respect to the rights and interests thereafter of the Holder, to the end that the provisions set forth herein (including
provisions with respect to changes in and other adjustments of the Exercise Price) shall thereafter be applicable, as nearly as reasonably
may be, in relation to any securities, cash or other property thereafter deliverable upon the exercise of this Warrant. The Company shall
not effect any Acquisition in which the Company is not the surviving entity or the Alternate Consideration includes securities of another
entity unless any successor to the Company, surviving entity or other person (including any purchaser of assets of the Company) shall
assume the obligation to deliver to the Holder such Alternate Consideration as, in accordance with the foregoing provisions, the Holder
may be entitled to receive, and the other obligations under this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">1.7</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Limitations
on Exercise</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Notwithstanding anything to
the contrary herein, the Company shall not effect any exercise of this Warrant, and the holder shall not be entitled to exercise this
Warrant, for a number of Warrant Shares in excess of that number of Warrant Shares which, upon giving effect or immediately prior to
such exercise, would cause (i)&nbsp;the aggregate number of shares of Common Stock beneficially owned by the Holder, its Affiliates and
any Persons who are members of a Section&nbsp;13(d)&nbsp;group with such Holder or its Affiliates to exceed 9.99% (the &ldquo;<B><U>Maximum
Percentage</U></B>&rdquo;) of the total number of issued and outstanding shares of Common Stock of the Company following such exercise,
or (ii)&nbsp;the combined voting power of the securities of the Company beneficially owned by the Holder and its Affiliates and any other
Persons who are members of a Section&nbsp;13(d)&nbsp;group with such Holder or its Affiliates to exceed the Maximum Percentage of the
combined voting power of all of the securities of the Company then outstanding following such exercise. For purposes of this paragraph,
beneficial ownership and whether a Holder is a member of a Section&nbsp;13(d)&nbsp;group shall be calculated and determined in accordance
with Section&nbsp;13(d)&nbsp;of the Securities Exchange Act of 1934, as amended (the &ldquo;<B><U>Exchange Act</U></B>&rdquo;) and the
rules&nbsp;promulgated thereunder. For purposes of this Warrant, in determining the number of outstanding shares of Common Stock, the
Holder may rely on the number of outstanding shares of Common Stock as reflected in (x)&nbsp;the Company&rsquo;s most recent Quarterly
Report on Form&nbsp;10-Q or Annual Report on Form&nbsp;10-K, as the case may be, filed with the Commission prior to the date hereof,
(y)&nbsp;a more recent public announcement by the Company or (z)&nbsp;any other notice by the Company or the Transfer Agent setting forth
the number of shares of Common Stock outstanding. Upon the written request of the Holder, the Company shall within three (3)&nbsp;Trading
Days confirm in writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. In any case, the number
of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company,
including this Warrant, by the Holder since the date as of which such number of outstanding shares of Common Stock was reported. By written
notice to the Company, the Holder may from time to time increase or decrease the Maximum Percentage to any other percentage not in excess
of 19.99% specified in such notice; provided that any such increase or decrease will not be effective until the sixty-first (61st) day
after such notice is delivered to the Company. For purposes of this Section&nbsp;1.7, the aggregate number of shares of Common Stock
or voting securities beneficially owned by the Holder and its Affiliates and any other Persons who are members of a Section&nbsp;13(d)&nbsp;group
with such Holder or its Affiliates shall include the shares of Common Stock issuable upon: (x)&nbsp;the exercise of this Warrant with
respect to which such determination is being made plus the remaining unexercised and non-cancelled portion of this Warrant but taking
into account the limitations on exercise contained herein, but shall exclude the number of shares of Common Stock which would otherwise
be issuable upon exercise of the remaining unexercised and non-cancelled portion of this Warrant but for the limitations on exercise
contained herein; and (y)&nbsp;the exercise or conversion of the unexercised, non-converted or non-cancelled portion of any other securities
of the Company beneficially owned by the Holder or any of its Affiliates and other Persons who are members of a Section&nbsp;13(d)&nbsp;group
with such Holder or its Affiliates that do not have voting power (including without limitation any securities of the Company which would
entitle the holder thereof to acquire at any time Common Stock, including without limitation any debt, preferred stock, right, option,
warrant or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder
thereof to receive, Common Stock), but shall exclude any such securities subject to any further limitation on conversion or exercise
analogous to the limitation contained herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECTION&nbsp;2. <U>ADJUSTMENTS TO THE SHARES AND
WARRANT PRICE</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">2.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Stock
Dividends, Splits, Etc</U>. If the Company declares or pays a dividend or distribution on the outstanding shares of the Class&nbsp;payable
in additional shares of the Class&nbsp;or other securities or property (other than cash), then upon exercise of this Warrant, for each
Share acquired, Holder shall receive, without additional cost to Holder, the total number and kind of securities and property which Holder
would have received had Holder owned the Shares of record as of the date the dividend or distribution occurred. If the Company subdivides
the outstanding shares of the Class&nbsp;by reclassification or otherwise into a greater number of shares, the number of Shares purchasable
hereunder shall be proportionately increased and the Warrant Price shall be proportionately decreased. If the outstanding shares of the
Class&nbsp;are combined or consolidated, by reclassification or otherwise, into a lesser number of shares, the Warrant Price shall be
proportionately increased and the number of Shares shall be proportionately decreased.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">2.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Reclassification,
Exchange, Combinations or Substitution</U>. Upon any event whereby all of the outstanding shares of the Class&nbsp;are reclassified,
exchanged, combined, substituted, or replaced for, into, with or by Company securities of a different class and/or series, then from
and after the consummation of such event, this Warrant will be exercisable for the number, class and series of Company securities that
Holder would have received had the Shares been outstanding on and as of the consummation of such event, and subject to further adjustment
thereafter from time to time in accordance with the provisions of this Warrant. The provisions of this Section&nbsp;2.2 shall similarly
apply to successive reclassifications, exchanges, combinations, substitutions, replacements or other similar events.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Adjustment
for Cash Distributions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(a)&nbsp;&nbsp;&nbsp;&nbsp;</FONT>If
the Company, prior to the exercise in whole or expiration of this Warrant, pays a cash distribution to all holders of its Common Stock,
then the number of Warrant Shares issuable upon the exercise of this Warrant shall be adjusted in accordance with the formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="tm2318315d3_ex4-1img001.jpg" ALT="" STYLE="height: 119px; width: 291px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">W&rsquo; = the adjusted number of Warrant
Shares issuable upon exercise of the Warrant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">W = the number of Warrant
Shares then issuable upon exercise of the Warrant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">M = the fair market value (as determined
pursuant to Section&nbsp;1.3) per Share on the applicable record date; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">F = the amount of cash or fair market
value on the record date of the evidences of its indebtedness, assets, rights, warrants or other securities to be distributed in respect
of one Share as determined in good faith by the Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"><FONT STYLE="color: #010000">(b)&nbsp;&nbsp;&nbsp;&nbsp;</FONT>The
adjustment pursuant to this&nbsp;Section&nbsp;2.3&nbsp;shall be made successively whenever any such distribution is made and shall become
effective immediately after the record date for the determination of holders entitled to receive the distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">2.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Fractional Share</U>. No fractional Share shall be issuable upon exercise of this Warrant and the number of Shares to be issued shall
be rounded down to the nearest whole Share. If a fractional Share interest arises upon any exercise of the Warrant, the Company shall
eliminate such fractional Share interest by paying Holder in cash the amount computed by multiplying the fractional interest by (i)&nbsp;the
fair market value (as determined in accordance with Section&nbsp;1.3 above) of a full Share, less (ii)&nbsp;the then-effective Warrant
Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">2.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notice/Certificate
as to Adjustments</U>. Upon each adjustment of the Warrant Price, Class&nbsp;and/or number of Shares, the Company, at the Company&rsquo;s
expense, shall notify Holder in writing within a reasonable time setting forth the adjustments to the Warrant Price, Class&nbsp;and/or
number of Shares and facts upon which such adjustment is based. The Company shall, upon written request from Holder, furnish Holder with
a certificate of its Chief Financial Officer, including computations of such adjustment and the Warrant Price, Class&nbsp;and number
of Shares in effect upon the date of such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">2.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Purchase
Rights</U>. If at any time the Company grants, issues or sells any options, convertible securities or rights to purchase stock, warrants,
securities or other property pro rata to the record holders of any class of Common Stock (the &ldquo;<B><U>Purchase Rights</U></B>&rdquo;),
then Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which Holder
could have acquired if Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations or restrictions on exercise of this Warrant, including without limitation, the Maximum Percentage) immediately
before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights
(provided, however, that to the extent that Holder&rsquo;s right to participate in any such Purchase Right would result in Holder, its
Affiliates and any Persons who are members of a Section&nbsp;13(d)&nbsp;group with such Holder or its Affiliates exceeding the Maximum
Percentage then the Holder shall not be entitled to participate in such Purchase Right to such extent (and shall not be entitled to beneficial
ownership of such shares of Common Stock as a result of such Purchase Right (and beneficial ownership) to such extent) and such Purchase
Right to such extent shall be held in abeyance for the benefit of Holder until such time or times as its right thereto would not result
in Holder, its Affiliates and any Persons who are members of a Section&nbsp;13(d)&nbsp;group with such Holder or its Affiliates exceeding
the Maximum Percentage, at which time or times the Holder shall be granted such right (and any Purchase Right granted, issued or sold
on such initial Purchase Right or on any subsequent Purchase Right held similarly in abeyance) to the same extent as if there had been
no such limitation).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">2.7</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Registration
Under the Securities Act</U>. This Warrant, as initially issued by the Company, is offered and sold pursuant to the Registration Statement
(as defined below). As of the Issue Date, the Warrant Shares are issuable under the Registration Statement. Accordingly, the Warrant
and, assuming issuance pursuant to the Registration Statement or an exchange meeting the requirements of Section&nbsp;3(a)(9)&nbsp;of
the Exchange Act as in effect on the Issue Date, the Warrant Shares, are not &ldquo;restricted securities&rdquo; under Rule&nbsp;144
promulgated under the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<B><U>Registration Statement</U></B>&rdquo;
means the Company&rsquo;s registration statement on Form&nbsp;S-3 (File No.&nbsp;333-258372), which was declared effective by the Securities
and Exchange Commission on April&nbsp;6, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-size: 10pt">2.8</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Voting Rights</U>. Holder, as a Holder of this Warrant, will not have any voting rights until the exercise of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECTION&nbsp;3. <U>REPRESENTATIONS AND COVENANTS
OF THE COMPANY</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">3.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Representations
and Warranties</U>. The Company represents and warrants to, and agrees with, the Holder as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
Shares which may be issued upon the exercise of this Warrant shall, upon issuance, be duly authorized, validly issued, fully paid and
non-assessable, and free of any liens and encumbrances except for restrictions on transfer provided for herein or under applicable federal
and state securities laws. The Company covenants that it shall at all times cause to be reserved and kept available out of its authorized
and unissued capital stock such number of shares of the Class&nbsp;and other securities as will be sufficient to permit the exercise
in full of this Warrant. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may
be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon
which the Common Stock may be listed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">3.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notice
of Certain Events</U>. If the Company proposes at any time to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(a)&nbsp;declare any dividend
or distribution upon the outstanding shares of the Class, whether in cash, property, stock, or other securities and whether or not a
regular cash dividend;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(b)&nbsp;offer for subscription
or sale pro rata to the holders of the outstanding shares of the Class&nbsp;any additional shares of any class or series of the Company&rsquo;s
stock (other than pursuant to contractual pre-emptive rights);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(c)&nbsp;effect any reclassification,
exchange, combination, substitution, reorganization or recapitalization of the outstanding shares of the Class; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(d)&nbsp;effect an Acquisition
or to liquidate, dissolve or wind up;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">then, in connection with each such event, the
Company shall give Holder notice thereof at the same time and in the same manner as it gives notice thereof to holders of the outstanding
shares of the Class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company will also provide information requested
by Holder from time to time, within a reasonable time following each such request, that is reasonably necessary to enable Holder to comply
with Holder&rsquo;s accounting or reporting requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECTION&nbsp;4. <U>MISCELLANEOUS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">4.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Term;
Automatic Cashless Exercise Upon Expiration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Term</U>.
Subject to the provisions of Section&nbsp;1.6 above, this Warrant is exercisable in whole or in part at any time and from time to time
on or before 6:00 PM, Eastern time, on the Expiration Date and shall be void thereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Automatic
Cashless Exercise upon Expiration</U>. In the event that, upon the Expiration Date, the fair market value of one Share as determined
in accordance with Section&nbsp;1.3 above is greater than the Warrant Price in effect on such date, then this Warrant shall automatically
be deemed on and as of such date to be exercised pursuant to Section&nbsp;1.2 above as to all Shares for which it shall not previously
have been exercised, and the Company shall, within a reasonable time, deliver a certificate representing the Shares issued upon such
exercise to Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">4.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Compliance
with Securities Laws on Transfer</U>. Subject to compliance with all applicable securities laws, the Company shall, or will cause its
Transfer Agent to, record the transfer of all or any portion of this Warrant in its or their records, upon surrender of this Warrant,
and payment for all applicable transfer taxes (if any). Upon any such registration or transfer, a New Warrant to purchase Common Stock
in substantially the form of this Warrant evidencing the portion of this Warrant so transferred shall be issued to the transferee, and
a New Warrant evidencing the remaining portion of this Warrant not so transferred, if any, shall be issued to the transferring Holder.
The acceptance of the New Warrant by the transferee thereof shall be deemed the acceptance by such transferee of all of the rights and
obligations in respect of the New Warrant that the Holder has in respect of this Warrant. The Company shall, or will cause its Transfer
Agent to, prepare, issue, and deliver at the Company&rsquo;s own expense any New Warrant under this Section&nbsp;4.2. Until due presentment
for registration of transfer, the Company may treat the registered Holder hereof as the owner and holder of this Warrant for all purposes
and the Company shall not be affected by any notice to the contrary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">4.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notices</U>.
All notices and other communications hereunder from the Company to the Holder, or vice versa, shall be deemed delivered and effective
(i)&nbsp;when given personally, (ii)&nbsp;on the third (3<SUP>rd</SUP>) Business Day after being mailed by first-class registered or
certified mail, postage prepaid, (iii)&nbsp;upon actual receipt if given by facsimile or electronic mail and such receipt is confirmed
in writing by the recipient, or (iv)&nbsp;on the first Business Day following delivery to a reliable overnight courier service, courier
fee prepaid, in any case at such address as may have been furnished to the Company or Holder, as the case may be, in writing by the Company
or such Holder from time to time in accordance with the provisions of this Section&nbsp;4.3. All notices to Holder shall be addressed
as follows until the Company receives notice of a change of address in connection with a transfer or otherwise:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">[___]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Attn: [____]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">[Address]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Telephone: [____]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Email address: [____]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notice to the Company shall
be addressed as follows until Holder receives notice of a change in address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Verastem,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Attn: Vice President, Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">117 Kendrick Street, Suite&nbsp;500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Needham, MA 02494</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Telephone: (781) 469-1694</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Email: <U>dcalkins@verastem.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">With a copy (which shall not constitute
notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Ropes&nbsp;&amp; Gray LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Attn: Thomas J. Danielski</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Prudential Tower</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">800 Boylston Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">Boston, MA 02199</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">Telephone: (617) 951-7000</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">Email: <U>thomas.danielski@ropesgray.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">4.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Amendment
and Waiver</U>. This Warrant and any term hereof may be amended or otherwise changed, waived, discharged or terminated (either generally
or in a particular instance and either retroactively or prospectively) only by an instrument in writing signed by the party against which
enforcement of such amendment or other change, waiver, discharge or termination is sought.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">4.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Attorneys&rsquo;
Fees</U>. In the event of any dispute between the parties concerning the terms and provisions of this Warrant, the party prevailing in
such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorneys&rsquo;
fees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">4.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Counterparts;
Facsimile/Electronic Signatures</U>. This Warrant may be executed by one or more of the parties hereto in any number of separate counterparts,
all of which together shall constitute one and the same instrument. The Company, Holder and any other party hereto may execute this Warrant
by electronic means and each party hereto recognizes and accepts the use of electronic signatures and the keeping of records in electronic
form by any other party hereto in connection with the execution and storage hereof. To the extent that this Warrant or any agreement
subject to the terms hereof or any amendment hereto is executed, recorded or delivered electronically, it shall be binding to the same
extent as though it had been executed on paper with an original ink signature, as provided under applicable law, including, without limitation,
any state law based on the Uniform Electronic Transactions Act. The fact that this Warrant is executed, signed, stored or delivered electronically
shall not prevent the transfer by any Holder of this Warrant pursuant to, or the enforcement of, the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">4.7</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Headings</U>.
The headings in this Warrant are for purposes of reference only and shall not limit or otherwise affect the meaning of any provision
of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">4.8</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Business
Days</U>. &ldquo;<B><U>Business Day</U></B>&rdquo; <FONT STYLE="font-family: Times New Roman, Times, Serif">is any day that is not a
Saturday, Sunday or a day on which the Nasdaq Capital Market and commercial banks in the City of New York are closed.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECTION&nbsp;5. <U>GOVERNING LAW, VENUE, JURY
TRIAL WAIVER, AND JUDICIAL REFERENCE</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">5.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Governing
Law</U>. This Warrant shall be governed by and construed in accordance with the laws of the Commonwealth of Massachusetts, without giving
effect to its principles regarding conflicts of law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">5.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Jurisdiction
and Venue</U>. The Company and Holder each submit to the exclusive jurisdiction of the state and federal courts in the State of New York;
provided, however, that nothing in this Warrant shall be deemed to operate to preclude Holder from bringing suit or taking other legal
action in any other jurisdiction to enforce a judgment or other court order in favor of Holder. The Company expressly submits and consents
in advance to such jurisdiction in any action or suit commenced in any such court, and the Company hereby waives any objection that it
may have based upon lack of personal jurisdiction, improper venue, or forum non conveniens and hereby consents to the granting of such
legal or equitable relief as is deemed appropriate by such court. The Company hereby waives personal service of the summons, complaints,
and other process issued in such action or suit and agrees that service of such summons, complaints, and other process may be made in
accordance with Section&nbsp;4.3 of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-size: 10pt">5.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Jury
Trial Waiver</U>. <B>TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, THE COMPANY AND HOLDER EACH WAIVE THEIR RIGHT TO A JURY TRIAL
OF ANY CLAIM OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS WARRANT,&nbsp;INCLUDING CONTRACT, TORT, BREACH OF DUTY AND ALL OTHER
CLAIMS. THIS WAIVER IS A MATERIAL INDUCEMENT FOR THE PARTIES&rsquo; AGREEMENT TO THIS WARRANT. EACH PARTY HAS REVIEWED THIS WAIVER WITH
ITS COUNSEL</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">5.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Survival</U>.
This Section&nbsp;5 shall survive the termination of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Remainder of page&nbsp;left blank intentionally]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature page&nbsp;follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties have caused this
Warrant to Purchase Stock to be executed by their duly authorized representatives effective as of the Issue Date written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<B>COMPANY</B>&rdquo; &nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">VERASTEM,&nbsp;INC. &nbsp; &nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 46%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:&nbsp;&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Brian Stuglik</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Chief Executive Officer</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&ldquo;<B>HOLDER</B>&rdquo;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">[___]</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>[Signature Page to the
Pre-Funded Warrant]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">APPENDIX 1</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>FORM&nbsp;OF NOTICE OF EXERCISE</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
undersigned Holder hereby exercises its right to purchase ___________ shares of the Common Stock of Verastem,&nbsp;Inc. (the &ldquo;<B><U>Company</U></B>&rdquo;)
in accordance with the attached Pre-Funded Warrant To Purchase Stock (the &ldquo;<B><U>Warrant</U></B>&rdquo;), and tenders payment of
the aggregate Warrant Price for such shares as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Wire
transfer of immediately available funds to the Company&rsquo;s account</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Cashless
Exercise pursuant to Section&nbsp;1.2 of the Warrant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><FONT STYLE="font-family: Wingdings">&#168;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Other
[Describe] __________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Please
deliver to the Holder Shares in accordance with the terms of the Warrant. The Warrant Shares shall be delivered to the following DWAC
Account Number:________________.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;By its delivery of this
Exercise Notice, the undersigned represents and warrants to the Company that in giving effect to the exercise evidenced hereby the Holder
will not beneficially own in excess of the number of shares of Common Stock (as determined in accordance with Section&nbsp;13(d)&nbsp;of
the Securities Exchange Act of 1934, as amended) permitted to be owned under Section&nbsp;1.7 of the Warrant to which this notice relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Capitalized terms used herein and not otherwise defined herein have
the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">HOLDER:</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">By:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Name:&nbsp;&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">(Date):</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 12; Options: NewSection Last; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">Schedule <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>tm2318315d3_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT><B>Exhibit&nbsp;5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="5" STYLE="width: 10%; font-size: 10pt"><IMG SRC="tm2318315d3_ex5-1img001.jpg" ALT=""></TD>
    <TD STYLE="width: 90%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ROPES&nbsp;&amp; GRAY LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRUDENTIAL TOWER</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">800 BOYLSTON STREET</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BOSTON, MA 02199-3600</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WWW.ROPESGRAY.COM</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">June&nbsp;21, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Verastem,&nbsp;Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">117 Kendrick Street, Suite&nbsp;500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Needham, Massachusetts 02494</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">Re:</TD><TD>Registration Statement on Form&nbsp;S-3 (File No.&nbsp;333-258372)</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have acted as counsel to Verastem,&nbsp;Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the issuance and sale of (i)&nbsp;8,489,409 shares of the
common stock (the &ldquo;<U>Common Stock</U>&rdquo;), $0.0001 par value per share (the &ldquo;<U>Shares</U>&rdquo;), of the Company and
(ii)&nbsp;pre-funded warrants (the &ldquo;<U>Pre-funded Warrants</U>&rdquo;) to purchase 1,538,591 shares of Common Stock (the &ldquo;Warrant
Shares&rdquo;) pursuant to the above-referenced registration statement (the &ldquo;<U>Registration Statement</U>&rdquo;), filed by the
Company with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) under the Securities Act of 1933, as amended
(the &ldquo;<U>Securities Act</U>&rdquo;). The Shares and the Pre-funded Warrants are being sold pursuant to an underwriting agreement,
dated June&nbsp;15, 2023 (the &ldquo;<U>Underwriting Agreement</U>&rdquo;), among the Company and the RBC Capital Markets, LLC and Cantor
Fitzgerald&nbsp;&amp; Co. as representatives of the several underwriters listed on Schedule I thereto.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In connection with this opinion letter, we have
examined such certificates, documents and records and have made such investigation of fact and such examination of law as we have deemed
appropriate in order to enable us to render the opinions set forth herein. In conducting such investigation, we have relied, without independent
verification, upon certificates of officers of the Company, public officials and other appropriate persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The opinions expressed below are limited to the
Delaware General Corporation Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based upon and subject to the foregoing, we are
of the opinion that (i)&nbsp;the Shares have been duly authorized and, when issued and delivered pursuant to the Underwriting Agreement
against payment of the consideration set forth therein, will be validly issued, fully paid and non-assessable, (ii)&nbsp;provided that
the Pre-funded Warrants have been duly executed and delivered by the Company and duly delivered to the purchaser thereof against payment
therefor, then the Pre-funded Warrants, when issued and sold as described in the prospectus supplement dated June&nbsp;15, 2023 (the &ldquo;<U>Prospectus</U>&rdquo;),
assuming a sufficient number of Warrant Shares are at the time available for issuance, will be a valid and legally binding obligation
of the Company, enforceable against the Company in accordance with its terms, except as enforcement thereof may be limited by bankruptcy,
insolvency, reorganization, moratorium or other similar laws relating to or affecting creditors&rsquo; rights generally and by general
equitable principles (regardless of whether such enforceability is considered in a proceeding at law or in equity) and implied covenants
of good faith and fair dealing, and (iii)&nbsp;the Warrant Shares, when issued upon exercise of the Pre-funded Warrants in accordance
with its terms, will have been duly authorized and validly issued and will be fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2318315d3_ex5-1img002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Verastem,&nbsp;Inc.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 33%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: center">- 2 -</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 32%; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;June&nbsp;21, 2022</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">We hereby consent to your filing this opinion as
an exhibit to a Current Report on Form&nbsp;8-K to be incorporated by reference into the Registration Statement and to the use of our
name therein and in the Prospectus under the caption &ldquo;Legal Matters.&rdquo; In giving such consent, we do not thereby admit that
we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules&nbsp;and regulations
of the Commission thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">/s/ Ropes&nbsp;&amp; Gray LLP</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Ropes&nbsp;&amp; Gray LLP</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>tm2318315d3_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>PART&nbsp;II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>INFORMATION NOT REQUIRED
IN PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>Item 14. Other Expenses of Issuance and
Distribution.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">The following table sets forth estimates of
the various expenses, other than any underwriting discounts and commissions, in connection with the sale and distribution of the securities
being registered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 86%; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25pt">Securities and Exchange Commission Registration Fee</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">(1)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25pt">Printing and related expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">15,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25pt">Legal fees and expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">350,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25pt">Accounting fees and expenses</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">35,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 0.25pt">Transfer Agent and Registrar fees</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; padding-left: 0.25pt">Miscellaneous</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">15,000</TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25pt">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">420,000.00</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>A fee of $23,175 was previously paid in connection with the filing of the registration statement on Form&nbsp;S-3.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm2318315d3_ex4-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2318315d3_ex4-1img001.jpg
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M *_OZ5ZE111111111111111111111111111111117,ZZ0/'/A8$@$_:P/?\
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MS_P77/\ \;H_X6%X?_Y^+S_P77/_ ,;K:TO5;76+,75BTC0DE09(GC.1_LL
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=BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBO_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm2318315d3_ex5-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2318315d3_ex5-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !8 $@# 2(  A$! Q$!_\0
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M+$ZVJF,'."2=W0=ZOZWXMLM$U"WTXVU[?7]PI=+6RB#OL'5CD@ ?C6/\*/\
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M#K!EN/LUI\191U\P*/J4Q_6@"I/?6$/PST!([VV:[MKBWG:)95+@[R3QG/\
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8>N!:&$^=LR6\OVSQG%%% SHJ*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm2318315d3_ex5-1img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2318315d3_ex5-1img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  9 )<# 2(  A$! Q$!_\0
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M%IYM(C662(F^_P!9%C<O[J3U!%8_V*?['J$$HENM4AGAEE+G)N8D?<NT= ,
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MYJ4:A#_:1L&#K-Y?FIN'#KG!VGOCC/U%83I>:KJ5[<1VEO/9A&LXQ-,4R/\
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0 !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>vstm-20230615.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaCHebOdzZR+GYkxtmB4bekaHyUg+QY6iiccp43mkQcA -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/srt-sup/2022q3" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:vstm="http://verastem.com/20230615" elementFormDefault="qualified" targetNamespace="http://verastem.com/20230615">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://verastem.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="vstm-20230615_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="vstm-20230615_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap-sup/2022q3" schemaLocation="https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/srt-sup/2022q3" schemaLocation="https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>vstm-20230615_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>vstm-20230615_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://verastem.com/role/Cover" xlink:href="vstm-20230615.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://verastem.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm140520233168208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 15, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 15,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35403<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Verastem, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001526119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-3269467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">117 Kendrick Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Needham<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">292-4200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VSTM<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>tm2318315d3_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vstm-20230615.xsd" xlink:type="simple"/>
    <context id="From2023-06-15to2023-06-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001526119</identifier>
        </entity>
        <period>
            <startDate>2023-06-15</startDate>
            <endDate>2023-06-15</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-06-15to2023-06-15">0001526119</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-06-15to2023-06-15">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-06-15to2023-06-15">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-06-15to2023-06-15">2023-06-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-06-15to2023-06-15">Verastem, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-06-15to2023-06-15">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-06-15to2023-06-15">001-35403</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-06-15to2023-06-15">27-3269467</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-06-15to2023-06-15">117 Kendrick Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-06-15to2023-06-15">Suite 500</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-06-15to2023-06-15">Needham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-06-15to2023-06-15">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-06-15to2023-06-15">02494</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-06-15to2023-06-15">781</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-06-15to2023-06-15">292-4200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-06-15to2023-06-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-06-15to2023-06-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-06-15to2023-06-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-06-15to2023-06-15">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-06-15to2023-06-15">Common stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-06-15to2023-06-15">VSTM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-06-15to2023-06-15">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-06-15to2023-06-15">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>14
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M/[&\UDX:?^:+X3]>?P%02P$"% ,4    "  *.-56!T%-8H$   "Q    $
M            @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (  HX
MU5;_7Z2S[@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E
M+GAM;%!+ 0(4 Q0    (  HXU5:97)PC$ 8  )PG   3              "
M <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ "CC55J)X'$]4
M!   %Q$  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q
M+GAM;%!+ 0(4 Q0    (  HXU5:?H!OPL0(  .(,   -              "
M 9<,  !X;"]S='EL97,N>&UL4$L! A0#%     @ "CC55I>*NQS     $P(
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9>&UL4$L%!@     )  D /@(  .L3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2318315d3_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://verastem.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2318315d3_8k.htm">tm2318315d3_8k.htm</File>
    <File>tm2318315d3_ex1-1.htm</File>
    <File>tm2318315d3_ex4-1.htm</File>
    <File>tm2318315d3_ex5-1.htm</File>
    <File>tm2318315d3_ex99-1.htm</File>
    <File>vstm-20230615.xsd</File>
    <File>vstm-20230615_lab.xml</File>
    <File>vstm-20230615_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2318315d3_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm2318315d3_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "vstm-20230615_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vstm-20230615_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "vstm-20230615.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "vstm",
   "nsuri": "http://verastem.com/20230615",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2318315d3_8k.htm",
      "contextRef": "From2023-06-15to2023-06-15",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://verastem.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2318315d3_8k.htm",
      "contextRef": "From2023-06-15to2023-06-15",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://verastem.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001104659-23-073116-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-073116-xbrl.zip
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M5R^(/"G!F6ZA2C;D@\!V45ZJ5JN%2GV[NE5Y%WK=L3!42("PRR =-!H&K'0
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MH*%G"6J<Z7D^ZQ9Y\BHYS^N\K6[S&D[_4B5_@)C]4%?5^WF1+V;)ZT4VS?E
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MK^J_V2XU$CN(7(( T'H/HN^7&;I_/D2#5-%X;;S/6VQDW+FPG^]PY!<*M:1
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M4'IIBU;+,NON&O&;>*FE$M%=<>H+PAUQA/^]OQ=;<]X-.CY4?YGJ/BV[DEH
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MN,"MG_2 G6W3C%F$!D.^_3?+31S]WV[+T8]&7RG:GXX&^TP6P(1 $RVWXJ0
M1FFIA"EW'VR)CX+QG$FMEPN4IB:+$Z!I;%R3^EI.P+^0IHP8BLW*8M7Y[H@2
M138E2RZ:$2H.'(:PVBKC&^<@:O59AADG"9CTXCR<-[']^X)^C6]<6]/D;W=G
M)'9&WM^NU(37UIJEGE9-*WESS5?W77[O2D@[)M,]G642 <!2A&DRW=21PR6Y
M*?H@#G0,DK8%\^"#\_.BS*COJ\4'\01Z<(AT(W9@ +G;!![H%3/+%S=4@OB
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MV.6YLKK'>B0A,UA0;(,N67W!;C[:XX8\Q-3/>B2VQ)%-?^))!_O2E5+@X6Q
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M#X-90!X<"T7<JHCA\SU-N*G#5;X"-)*5Z5K[IK?]6LCXNT9XX#>RD/]GB)X
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MO!]3;/":?)Y0>\(EVEU$@[=8^-X7IMM'K$?&K&B<)-I&&8?LP0Y)1+A1!M@
M9',MQ[P)!'U4#7?48$:H\2KCS^9<_ <IMD=?A&)[!0*\+(UCBIO^'+Y8%Q.*
MB;$N.\@$O1(E04?D"S^&D>G(1 @B6"^IR\"P<8%/TU1XQCQ5,@9FJK7KA4.1
M'A]%,L_P'1&D=_SE>46AG;I:-'2:[9<-+](RSTIQT?-"-(-KVME/<,$ ,HQ%
MX6C6SDD"D[%!F9@NLF))T.)E=L8T](N"%1P%E:D7 _>,)[U =2RNK?U:DV?2
M#T\L5JKB4=:TH(9'W*AHH]'D93ZCKE[X-NH-BO^[(]=QD5URHP&ECR88ZY3#
M9O*AZ58*\ZWF&75EYT1)?+84_3;3)8O<@+I<9,0A^FHB-60F2/PNJ/Y)UHAQ
MGG#/ ZJ_<^4?"6O&_ R_-/AL3@V"E;<*'65/"K<%@T@]+[B''M/-:X%)'*J4
MF@_'VB:R](1D7K+!VSLGKGV3*N)9V=;B,-KEM3]ZAZ:,(Z1X#S;N";W3]*K0
MO7!_P_2(=J)E#CX/4:,-41^4@K@3V;Z9^SHU=YZ"CL@8,TP8-K*9? 60?I>:
MAA3-(L_83V3]H/K'W\JD%$AR52<AAA.MBS6WG-0+40AH,3LO/C-\#R9H0)*V
M=:J+R]B>:V/W:5%>Y'#7G+F\-I@:KFL!5;C(R9)SI<<J=4>*U8. O79OJC5H
MEDPY4C(@;!:=R!HQ+D#X1L,CZ[X1&9Q5<&N6G<8(#QB2O?-,#[K*H2:ELE'B
MJ*I618+4#(P(?3YYJ9X=O%QQE+0;2FAIT<J#9(ZN''72@X'85GK]^T3-NR@^
MB".24U8M7+:&T$4^3SANS*@4C8IG:^U:VK8)[Y4$D.GH<!9'E][=(8:&<FVX
M<M'X^\\(_WX9%'&;C:P7E#VRXN/]A%[;IAT-*K/SJ68!*2%G;"K[9[6OT$@"
MW0/KW6RX'=/-ME6H93[.KDJ=[N'">59 PAF$89FSBIO#Z GQC.#>,QR:E1/4
M1>7"\8YI>2B:71$5H#VGZ(21KK*;M%E!A*TV!S_^. 4A.8PPB!N@RT?6YVH:
M)1E1*#TMAY#R@58)S?^I*\!N_!7DN6C-+1X$(AC<';.C(MAO9 17*_B<+W_7
M84('BZS8G!KO=3 '\:QGOC!##3I'5X4;GR^($0H$'"T1E],)6WO/B[H1-I F
MQSB,?VCCGFKZ\':3WEA?UQA!AT.&2_YOL</?GL.2)*^KIO"4%:]SL$IA3WXH
M9J[]F!UN\ 0XS6O%OGE">UM?09W"Y9$3>&1JD]MDX)5DT\1N1I-2B0@]S9,U
M6:#>FMZMMW'#!V0M.]G,M_]RVRU@?_]K"]@_N@O8?[&VT^?A*MV&TX*KIJ4&
ME]++;YH7*XG8#AT\IX'[R<U'J+!*EUMF$,%RB<+G@@ETH;%>CKN/=)>"RD4@
M 'M&D4 'ND&F2;D$D.QHU]3AT P7\_GB/+HP&U:,3<*",<*/<-K</FI_CY\5
MFY:,Z2E91G2-2<P=1CCR.!F9!R6@V@8M3U@5M,)"RT%A+& J[.]1T/D*<]K0
MSZ1H/?.&AA06&-W/?^O@OH,M.; V%FB&.9B=E$Z84U,5QM\AN =SR8WSP<%G
M/43QX3(.7@YF"?<)&2GN\!;-1Z\:",NV9>-0/9ED$9'SYA<E,*ZPN/>25T)+
MDDD_$^T#&KQE+*'SR#U9Q$_3^DI%VAMJX7A5,<Q#S3YMF6!8RTB&E"M_I&#$
MU<<W^?3Q:4[$-\5Y%CVGN$T>T9LGM'D@4Y>E1HAT+B)COJ04[6J)XJB I8G$
M;B1NXZ ZO:%'!>M SHP+"O::O0Y$Z##)%@TII"TKM":)*<$Q@[$Y7%)T0%2-
MX@)+:.Y%.[@OJUKD%E$XIIG]P!6!XY)?X#9S>WO-:,%)SM'.AB57#Q!IGR_+
M &2"PXQM=R0N1_'V,D\\'-2] %4D082RFL/E;')GBD+56EUT6'_KZJ*9<8\F
M5]MLFAS1E\[RDD+R%,/2'&V=3(L:G#L&<!'@:72_?6M'3L\19'FDQ^\PUJEE
MRR2&OL^)"*92?Y%SKLQ9NBQA4U;O')J7Z*U3\)P(-6M*GF0:'(]3I[3_K0;5
M=VLP9:J68_<Z!3[H4S,9Y^L)312EC>#++E&.15 @6J)@1A[.^AD3.S[V*A7>
ME/-(7!\G<>TH-\-,P>ZQLG2AYX@%2OM[7*%$ X25:6P6 L%QY/' B7!ASWF:
M4%X:=%JW6-EPL+V),+P>\<IBM\CM=Y?^<\C)-]NSK^8$@',0R>B=/\*F%-,3
M0>8CJ@=&M3,"(4F']LQ=\W3;X[IH_?5I]/Y0N^ HRHQ,L3YCP(B!P48J7#ND
ML 0-C6H/[]B^O@/CVYWZOCH 940>+(4N,)WD[I]OCI-9MH8UZ'L1@ZGWS.D,
M?<XF*V:Z%:DYWF/K%N.7#YT/5QW1GP*L-*JK=G_OO@S9$77VOSK)\8W!A$7[
M[#8^ W\7"9H--*13\R41 ]4SRK7X1L5*M1ZPB2K!7V_ MU\+[1:T>?"U!6T>
MWP5MOMA+[B:HS5\)E22[$<Z+]H:@+;3HDR9EAZEW9-&IG6YB47J$.K\K?:=1
MQC449=-ASJO0BOTP?Q:]=?4VXTQ_"/S3K,0(VH_N26[D+K@I5YKAVIWN[XW!
MAO#A 9#&P_^N@D:X$@K!)]\.884KZLG#%'2V A''&Y0=6OQ2L#A294$7;@R'
M*FA\M9VU")L@A[7@SAKJ6+O"O]74L):,F_E"@FN2KB/GH<SG13O>_ERA*R4F
MK4IFHI2O!*/2[]'BJH.)H9(QF,VN2 R"JW!<@^_:/H#@P%-:R=+8,Q%@76%E
MEA4,IK,CU]2EBMGXD ^YJJA9@?U46*L-GMJ5-%0<B^=\=N_!Q\V*AN@ "1(Q
M]7WZ;&^^JH]%4OSHS!E8=NK.W;NG &E8H&HJ^&)=!=FN8KG,9R@,'/N;YBR\
M: DR\6]X^C_A#/,^F0,\E-%D(**D6U1&T9ZB9)I81GUIQ0 #A6("868$<@_W
M'!/@V+&R DP1BAAJS#8O]>B:1DXRB 8,@.6.!L[''N=ZF:/D,IK2=?GA, W"
MNEI:<K3+"\0>4H#C7O*#3)=(2:*GTY09Y4O7:!*>F+G05%LA7KK,6^4K:SP"
MP(GZ =L6\)A9QZ1WJA\/K6; $"Q#&D;U1B@2NPXO>E"T^$Y/"I.\<0$QZ8.
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MP5LC#K2P1RH@5,X<P(.X:F1\L/F+C^*M\NF'N$67SP"GV#G<Q][4L0-?Y?T
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M@-P9>AG? _ "C&].TARC*/$,R1-/;7Z9E$XLCH'NQPN",<*D0RFV830X#TD
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M6(4QJ3%H<:[MIK4?(+0@BV\&J)A&?;:8.5RADJ \.HBJ=319MLI^I9&ZK+\
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M$Q]"N]DXBW6.GY4R*VFOJ!\XJ?^91A@\<$8I-S$2,0TNS8C2LX@D +J53,"
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M:NQT(P#1HA ^&I*!%"@4*$H7 3?,0='G3A7!KP$)ZK',773@!L5L0&87%$5
MN5FR6 W!J1(XQBLF6K8N-R=E=R32B5PVQ,"XQT#QH?1-))<;#925AP!H+Z8V
M0!"JN/C8C#4K;RHBJ1]EB187 5Z8"\>W44*G4,SNF]"P2A:OMSA$K*C56ARM
M#"H>]]#I6^&(O $/I$LX)AQ^,9?Z5R6_O)1.DX*07)V0#(Z6T/IHCJK6F/B4
MC(GO#[O8 +YUW#XYZWX;QL*G2S(6]D#1VVTV6K,\P?LPH(QB"N$V34$H;K-M
M<F$?1X+Q(V_ A\<BG?>Z1>F!:MF 4E3^<^F$ZYIGPLPINF"G.,/O&./B:$1L
M<RG1/PI%P H2'&?U_-7FICI][ZFVGV&'$*&1HDP4R$(N3R?91UTDH=1>IMR>
M;P>5EM1IRUQM$#(J=WM6<[?=CEO(P*QXQM+1>@L2,!>G[G&ULALEER#BZE)7
MI)A4XHM=1SMGF^E5Q759\KX&!H9&D"UIB(UQAVY%$#.06.R*"J!7)))*%^I*
M!S'2 =E:9&R#J >#-G41)K,,UV%U\"H*>NJ(ZE+<]^)6N+J/CQOB[?3+LXJB
MV-9=W##J-[H3A*[$]LU<SJ=+,F#AV4:A6RY?VTZ._$NR8.OBY7PY+78P,"]+
M7U%$\,+.6;):US569@T+7F/[-,5KEFJEHQ-0PE<IGEE_FY@.JF1:6U '%Q U
MY-S?G'J$\DB9I]%N09-HCTW>4W].01?4BL3=G%E'[G\.,-^,C!YK5O4ED<.M
M* Y<A;SFE9JXVS'H;E%I"ONT6\3J2AJ5O4IBM+YFBT ":HA>11H,W>S'HE:V
M?B1@)PCF;=CK+<U5E"M>-*NTG[=FIEAF[CEV]1+2(AL1Q!%4K(!\!U-N$BY:
MHKTV"6PI=F 43ZM6/!'=W!VK+X=FO9DX#32*KGH@CEBMP8JD\;KUF(YZ5H_(
M\AM7-I.KN2;F4H+H;*X)T-DII4 2'#VG)7E]@A*U?94<)4):>]U6PS.'U0"M
M C2GX)+A# 5"HNY%32 7YT<6SML$ !T5.3)702!\AZ(!-93$W,#141103!LZ
MKXV&,5=4EW7G"URA.#HHVM<]C+$P&GSIUM37;9 >/ONY65C!BV\KK.#%][""
MAR7;+*=6&3OG,E%C6Y)^.0CL"O$@PDQFL2Y,IXKBM*R 6N3#Z75"%/D"*086
M!_>]"F<I>D]0K( .NK1:QV.="C*/QM)9$YF[9R6NZP2N\Q!$G]6=U]VSTS?I
M\/43_+FF]F99B 5/0 O212IT]P3JA@-TC=IDK+,;QJ*OF XJ\CG\A8\#YT@R
M2DPA#A(./;MQ-M<;8 \,E;( U #.S4O':?P!1?=SR;)2AQB3[6'>-.UE1!73
M&;#"M>&Y<!J279J:?%VXT.#6'\[F"_.G )U=^=CC*.28!O@LIE2$00("*3D(
MTPO*#I4/@&\%UN;#HB.-TI$ _G"84O=4CAPH%"9)<JUT&<'E6V&<Q%;LID75
MK9LN[4GJY(E\247'$N/>V5#V/3!ZEEW#C?9)01\FO,X*)2UB]JBHB;'M4P*,
M1 [C[P*N&O^#;\GP5A7EA^\%I_^+3^E??_SQQ[_O9>16GL/'./X]3?"O%I_-
M_8S> PHP/4_BX![WL,#ETF:*P[N[\^F767#MN*[CDU5AQEQ:5;FS<K^ONJY<
MO9^ ]KBA)2CX(4C1*#SQ> F'\>#NW#>W6 9?Y \([5, +NK+P-2XQD&PC 5M
M;;U0_PSB81J"V-X%W2N ]71G82YY/,\V-^\M T/P. B&Y_[$4^];:G/[Z<NG
MRP"#1:%67_RTM::>/G^YOO7\#A=S,TKU"CV-PX$??0KC['\O!&DW0"+E+*&'
M>A.OW=U'YO*#9#I7JU)8Q.C>6.B:JX7K1G9K' +W:+?;2::ZN^>/_F2ZJWY)
M0<0[.CI='M'IG<.8F?IU P3D&%3-[%.XC,6<IC/\&_.&>]@2ZYZIRT^;FVHO
MF4=93M93I&_W/.->@G,).=MZ^7+9Y.SYUHLU]?+9UOJ+S3NDY;<@9SDAWL90
M8]W_8HQF-H8+\?#IVIU9.Y93\["%^;1LA.5\*U2%J\G9II(!^D.UD56"QG6?
M8Z?EC^GX<(DC#BDZ#CY+Q_R@KG^)[9&#D&PJXR#&!(:(-5ER%7(="XJYQ:9Q
MI+:2883?2(,\37RRD$1S:0E%QG'Z8$TE,7Q,EEJ[YYRE06=P9D6..<X&#X]]
M?)A=G]A%;Y2DTM#7U';2,"MBAW6$)>TVM79K;U8*B6;);'S^")(H;V8D_NG;
M,A+_]-U(_+#(YG+J!X+ E*1Q,,_$)=9LO UTCJH3AR)1[4 /L/8ID,O\,I J
M/D3= C)L#M#4*$Y1*;W%+>(6M%KQ+(*% 1G 2*F81-QLZ-K%-)VQS]G5? :@
MZ:,'T=BJI3H9D[^(V]JA#8Y[Q)D*0C*H7??*3I&J0&0$$'GX5.[.$'$YQ>_V
M,;(V2/'P,L1";55_TBY,ZEW8FI_/TB*)VF+LPL2#S\% %^?%$"A@6]3?7AS3
M&E>E!I*8NJW\/70A8]C.P%H/AD.P%URRSI(QI]0P6A8Z'<VH':\4#5[P:\>Q
M;7HSNJVN&75E;;@AV8US9RA.VG8T4 T-$B<P_MD9 ^,]QC% 6DHXD;.?K?$S
M3B2U!LH,>,T>/@7!E,*==7=&KJUBWB&/]T1[D6LV46, EZ3&P4P:\%+#W12)
M/(MC *AJA33'V2U!+Y07SR)?Y@9I,ND1Z4X_;80=O;3,((L.L6&9KG!>%1ME
M[U1HU>7JAYPZ8M5PPA N7<0)\R#'%'*FJS@5J)E@U.=42H*B5)>D(5QDJAG]
MJ3@&S\FPK"3*1OZE1<*\NMI]* O/)8D6TRZIFJF.$CV+0SH\ZX)15(4OR;NM
M@> LUDFM.04'?BR!4BY:>C44*<'!BL$+I!>Y\8H(,M67_; C #V):U*N;.M5
M4. ;(M[+*97U+J ,7>UK1J0YEX\X-\96P%(N8:<C59BV4.\[-,RCJN/6\"-\
M=I4R#E^A<T;J)Q1*<DQ9U)"&ZH^WV,L7(,%R:OEHKW2S<>#/A4,[-:%LMW6I
M$I2JCC[R@?W/7UT-P94W(9>['6(XE>3Z2)9K%XDH?(Y&_AB_1T9 #YKBI!2J
MYF=#_S]J7[+Z)<D<41"#(S B%S[M^_&G3*=Y[8? WP"[<$V_)RE7#1U$B=-X
M]E'A6FTNT#/*!?KEY$.[<WQX_(LZ:GWTU(?V\5G;4[^>=7Z'>]XY;!VICZU#
M>,2CDD._GAT<[N.'G?;;=J=]_*TT0W^VI/2A7SBX ],&C_S+&JFXJ(9)3^J(
MOR$+K>EL<;>ZB,*?3=+R)(DO S_"/J8CN"09B GG,ZS.GA62QSB\H*5(2@#*
M6#E*,""DA-,HH# </Y5RYO$(!!DN\@!3?3/4^=F2(MU_G:5A-N3"+&PB_1#$
MLZ!:C0J_$ME+\BG[5(I$R^0@;U);TS^M 36>L*1)"4Q<Q84BC')#.:D0H$TZ
M=ZER8FV99*#BYVP+J$LDL8*8$X6%$"1;9(IYX[-AX 0/]3&$FNRD,Y8D<O\3
MR0RDKT2 E%ANAG<B&B%_Y>R1LD5)T 0V\N=L."Y93G&GBJQ_.,C(O^"J)A*Y
M[< X^(Q1PUDT%^AFYDIB"BFGZ POZ#[JLL#.4F21LF2*EPISYE?Q0*ZT#L&G
M=56S6:0K,MEYI6(\J5"T4RZDTVP4H5ZD.% H'!DT85\Z:L]9&2@D$RY,H2X0
MO4A$!YC-)G">,=>BCTT-(5F#WK?&,:K&*S(=9\;0$5%\W7]@H](8+L*>"1A+
MGFE4 .4(YDZQF+ )9J?MN]!WMV[V(5%Q!I=G2/.H@/YD&ODAE\,O0B=AJ@&%
M>''0OC8NE<[$JM_&976*2;CF=,TLJCJ)&#>H=1<:QZY,X'JZL?/X*AW>S$C_
M\MLRTK_\;J1_6+Q[.9'<P+OGF!B&FHCMV 2UJG="A3W?GAT=M;L]U?ZMUX:Q
M3MN=]X>]7OM [?VN6J>G1X?[K;VC-HOP5B%0DMG?G1P=M#NJW=I_Q[(\/G'8
M49W#7][U%$S0(G%?D;1/I43QS?VCUN%[==)1^ZVS;EOAIZ0[J%;GL(OJPLE9
M#S^%)_9:75C)V2E\V7MWV(5).IW6<4_'IQWO'X'6 &_L Q@Z, HL\:0#_]_K
MT)I@D(.S'J^U=72D3F!YG6:#%M#=T$.B#J+@MY9ZW^JU23$Y/#XXVV^_1X"\
MA67@OD];G=YANZN[V[9^Z;3Y 8)CL;8-!@<^_KMZU^J"/O/AL/T1MF%/]_&P
M]Z[9..QU8>EGQ]WV$6JT#Y_4WJ[7Y8WZL3];DM>_.P-V>N%'QO!4COE^)O)B
M1@\&QC1H]:Q\7'RR7G'_5X<R$,5@BB2?IXV"4:[ZD1]_HG:$,5>JBN:/)B[8
M;-#X?JS=2:CO ][,S:2:K<UO2ZS9VOPNU]Q'6)Z0ZL-CY$S'[2XP*F"5[9.W
MA9N=?)^HT5$J[9"(7[-AI6&;[B5<3],48#!.54XD+U66+:H<^#EI546=?;^F
M,87IFT<E&^[1/-@CL0>+&9VV#E#(^'EE<X7^[IZV]O7?&K_X^F!8@3_- ,7T
M;[N@9 WS<US0Y@\KA":O>QW]&G57&_B1OCZ,>BL:FWI8B!VG._YY97OEMANT
MVRJ8ZNV%V5QOMW=@37?[*8I1X'^=K[W!O\$>0!IL=7OM]X5,NR%G\_V([FX/
MMR8.<FV?PJ7=F[^J7__53'-7W7ZVYS_<#<3,B,\V?_CZT%MY0VS;[5S_90BP
M!QHLAJ;/QE'XZ;%AT\J;'D:>+<"BFX_"O5[;'  #_%%ZO2X=''\' G%'C)8M
M(A:??>0;^QL<CB0</^8M/)!CN#W5OF_.^7A!0QSR#I?]J#9_-^SP'G?_A+0_
M4@3OSFZZPSKV(D6^SHYRV^FNL[@<VM8P,E"PX[39.$V#];<S2F(2E1YHYN$#
MMF;>T#ZV]76L8C<Q#GVW1]W:=MLZ/6T?'QS^IK8>+B+6K_SUV9NW)YWW/-?)
M6W5\TCO<)V=7^[=V9_^PVW[\.9TW\N]L;7Q]]TX/*1I%O4MZHU49KS\WE5J=
MUM96&<D_BG_E]@YVPR#XK*9@AEK%!YWH58D>*06NKM76TZ7"BGGN#[ N4I4H
M8X)#R<Y:G4^>+<\GD3Q4MC,S%3IU(UQ_/,88N[Q<IW>D:RH))!Y3Z\"*N])@
M;CW>ZL#ACV$\IA!T6-$_MI[_M'NG*/PQ3 $][7*LX602##'V""WCIJ/8"$X^
M*Y6N*3<4^ [[V_W0=;2;#5-(^\K"T'+OS8WZ#NW;_#C!2+1FXU\' ;91Z@?_
MMDGK-?^^ JQK.=R=^M.N:YW\]5GC:13XV!%05[=UBC.: N/U?(D3H]PKP?&1
MI6Y_5J"MSN22>8J2@P<?6_O-1HO)F#JF-,I7921X;$$55\I).QOJ;DYX;TZ"
MBRG:*)$H%DWCLF?LN[7EH,7]@MV*G13%&TM4OBJ"\G.[EZA4L@Y,-&Z!2%@2
M/=(E@^, VU-B[ @53<8LT,\4FBJ85-<"TQ&T5ITV!'78Z=+M'=.W2@LW5FUV
MTZ6]Q16DMU[N/.5VX5S#8TTZ:.:,M'VNH*R3*$L,XD7I-N ;.C\H-"7CTB "
MWOZ0^_NLO-G7C<YPVW3/R<DOS3D16? PBSRZ(1QJ7#R @0$,:BG.C?X)2; #
M>A!0F6DXJ-!I!?%0W/>5F):_Z,^OC',KVYE#IVN-6U]D1&;7Q*N%=KX'O?AK
M;)1+6/N]F+ ?R-X>WMH7.K3OP$7^=5W\SZYWR'\_\<5KOZ]0A._7^0&L_4X=
M2=]/] &L_=;K7<4@S[7E'*GC];LSD721J&X>OJ$G:WM7G5 GZNP5KD T$77D
M9[F) ?]*WJZ[BP'OHIU[%@7J+P6#WSP6_'I'F'4<I1-[LG=R\/L;_.5=[_W1
MF_\/4$L#!!0    (  HXU5;FQD+4X@D  /HH   5    =&TR,S$X,S$U9#-?
M97@U+3$N:'1MU5II;]LZ%OUNP/^!8\P4+6 [7IHVBQ,@<9PV[[E)X+@OZ*<!
M+=$V6VTEJ2S]]7,N*=GRDB9YD_2E+=!:$GF7<U=>J?-Q^*F_7RYU/O8.CO _
MHS^=X<FPW]OO;+C_\70C>]PY/#OZPBZ&7_J]O<HXCLP.:S82PX8R%)J=BFLV
MB$,>5=V-*KL02HXKV(BMY_F^D*N)C'98H[+_*AKI9+>S<;ZTY*&D=]F,&)8V
M=ID1-Z;& SG!+24G4U/9[QR?G0[W.X?[O9NI'$GC>&[6FYV-0^CHGCZ5!"LJ
M#0\.^SW6[?7[%^<'W9/3#WN51L5>GQ\<'>77&=-KZ9LI<6W\9Y<]7()1K'RA
M:EX<!#S18H?EORK6HIWA(&=P)921'@]RB$R<5#*K=X9';'!V"2E/]RJ;JR)E
M$M6T_"&<6(#VY-,'=C'H[E5,V&HWM]K-3;_]7W&S66O*<-)H-.M?DTF%'?2'
M>Y4*^=-1@=DB@^WU#,@Z19/4QCR4P>W.?9"L4!J<G?<NG&U>\3#991\&!U\8
MK##S  B'?P:/A*PHV_-(?C[X?-0['9X<]-GP[+(W>/$";S4:[/#L2_]B>'8*
M@H->;_CB93X\(VFK[-,!:[2:V]NU]KM&X\5+?7EY6;>.3<Y<[YY]6B_QADU"
M:[-P#3+O4.+,+D>Q,7'X'+GY&0C^D4;"$6TUJZS5:+5?LK1_"<6U$6'543Z)
MO/H34F\VW[,_1>0KZ7UC%T8)8; TE29#:)/<^<FXG0KA3WF(>.%:<V^::F&,
M1NB\W7[[*VIIL78NU];+DZ/AQ[T*%='*WY4@"XO$K :&C>![<\!J@6MD!7#-
MDWIK4T8H46(G7X'?$ZF-XD;&$<S)X3<B,@P7Q[$*'2X7M39[?2P#P4[CNKO5
M;K=KK<VM]OO6FWD.6!__+R<P^MR76,XCGWV D@&INO,+(KG8*WY-M9'CV\=T
M7>LZ3QGY@O8WZM:BEX)-^95@W#/"9URC,4LC+0)X"5N3#JKE$F='(N#77 FL
M54F<><!K,Q7L5>!_3^/=SN?];APF/+KM;'S>?Z7LS3=5)B-LB2+AV1W7TDP9
M[9):ISSRA,57<WA+/&:OY1O'=JOZ=FN[^K:QS?043#4]Q*YRR8O#$&2TB9%/
M5MF'UBWQ;%&&?S?J#;1]+.&*7?$@%2P1RI%>)G)A^2UN=\Q9IAY)7"Z]EKFL
MB1*U<0J$?0: %(^0<9:(GL^77&9+BAP(]R15WI1KP9K5S?96=7.[65"]J-D"
M[8Q:N>3$GA$$-8+7$&5:SD?QE:@I,19* '2?J6(@ZUD@+\F]/MP7P1DCTGTV
MNG7VR3&:V?E">*F2)H^DW@VTC"86S! ^L-Z+LB<+&!%\:IGD@6<(G^9VNUTE
M1^:0#RC#/$M67=A2I%MG0R+IH"8):>,:>S'RE9&0T83I./ 7$.:1D^Z:6& !
MGZ#.$5*(')]3C,U;@N:F:PF6M?Y<)'"0$UB$FL,))LNN:*\'AUW6Y8DT/$#M
M4]^$04+H][MV01=BQJI<.I;FQP3A'?C% T<WKA-R2L"/-5C"V%>S@&-:7-&.
MN7Y":1; *: 4^80W%7Z*X#VAU4J8>$WS\)0)[9],FR?K,ID$5(F,Z$Z 9D.H
M*KMVZ;5<$C=HH",@I5-ORCPJR6,494-L_=A+R<+.Z91 6O7=;YN:0^X+MTU&
M,(>1$Q>$,,L8:=ME37KL>,P>(DF3-3,1F$]NA'#@2:+B1$GPIH1L#^;DN2+B
M(U@OU72AQ"S$,I4T[&\ HH*J9%X9U9E#P4\]ZZFK(L[T![U "K]JD8I3PPC.
M1%A,RZ4K@IW L%O2!.(7 2)=XC$NR-\6\V\5L3<*I.>>2QXXV&)R0%94%#E>
M0X>G;&>?9S"TY&?#H@'$#<6EIA0K@OC:IJ% AI("T"7W<FE6F]&GV&CM%FIT
MGU__"@2>/_P..:%@/<5Y_^@K0C&O<'!2,8GADM;_ $:YE+E-'IYFRLV\PS#S
MK&^==21$Q)#*D%-3N*O"<=8G/B WQ1-J5]P-Q%2 #*F$OU)EU^=P1-^$RT@;
MM!^WKEUV@B&,M,2.K C/(LVX4*/ "0((1BV+]"&9$P(E-PUPE7#I!(KBJ(;S
M#KR$@KG*BJU)?"6IBI'NY=)=I6T) '&#:FE6M'4E?J'TV.7S%1D,>2NCG";0
M=@D *PF:D1C)TA"Z=PBVBKTMO<AOOM">DB/<E6XW--4)W &93*=)$KAVYJ'%
M]WRV>Z'@PG)@'=J2#K(VW1#9* U'T Z*99+.^@?$()R,B!NX-^-77 8VPT+7
M6<L[-RQWIK6J!6+"R:PCN#UQC)'C7$:=>?(L 8H(]#QA*>?8%FT#4+A'%<5V
MV+922=@9U2D$J.+&$P@SP)C1L5CEM@KY+8F6YQA8?<2C;RI-C'<+1, K#J[0
M1$(,K%<3'LD?618/*><@=-(0%29+R!IT K3=R%#49 3<!@<\!2OX>"Q<&?'@
M/A);T<%JPMX-R36;N(06.'>#+-D-U-;O*;H= @#9/O(D3(ZV&SF *Q\_;=&
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MQ-U_HKK[X\(-^G;1?<Q(WSS^#U!+ P04    "  *.-56*T.$4!X$   0&0
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M &+8M.-1B@*$H^FL#PVA]@G&59)%.%5>KL2VK*-Y%JUK0$"[)B0M85"@0.Y
M6%2 9J8(\0K,OPCFPW"I*?W TK)J1Z62!0B*Z:T/$ZGW LELRWG#-3SCP%)G
M-V5[S%;W9P%=$*#TF&O=M57R!BB>9J!+FB?Y7CY/=[/=K BW-*XM<<4&9$XS
M898'P0)@RF1 R9#4(27TTO/Z+@'-Y4.,8'-,F5L"[":;%#0U 9%@-0;0<- 6
MSY1Z(6(F1B:.TSF-R>YGL@?;U=*Y90*PV83"$ 5$A=T9@$4I1H4:";D7,.YX
MLL%\OTBBGJFB+72+!F2TR8:I"@@.P!I 1ZE&B_G,YTRRQ+MY+$!-'A+U/'@/
M):#>+2P]MIO, .* T.EV"! D@E SRB=(<QHQ_LQJCSO,V%8,@/L9B^$52D^4
M6Z@&-:&)5F=(0( -\0E@U@C]H)Y)04R^QU-4@&0-7HB[B&-QH++RG^N$DF.P
M_5:M6[HZ[#:9L@@#(@EV!_!3*C_H#TC&H%L:"C33-S1UZA^:Z5!HID%#,WT/
M-,M7%@@T)V]HZHE_:$Z&0G,2-#0G[X)&=+S7L68F/M[R)7NU/9P-*KT@T[9J
M!>8@"P^7EK<^6&2 7,_($)^8% NK6W['V4M"(WC)#,F]  .8ME)C:,-#QVZP
MCY]J0:SCO(XU:E'>^R71,C^C3-.D?8A1FO @:1KK'5R4VB<2=RS+<?KOY+GS
M1-PN]H*'U; 5DH8R/%1L]OJ 43%(!/DXL2YQE3<TK*^2&>7N7@&VV#J\ EPK
M# ("FZ/V*\#JZHD2N>YFR2@G&!@1FL7..MEBJNKC6ED87=PVU.KAXGLM-#Z^
MR#*[2WKWR"C\@$!;XJJG(7.ZM\WR('H<,&7V>B%#A<[3U7B982*S#]^U,F<S
MNVFGFLAU01"]:[II3=.ZW'%O_LJ37.QYQC:;+2WO\MB>&P1TKGJYTZ;N<:LH
MB-[O<F:24&I14^P8BP5+DRC)$[K^19Q\\@3;6F43N0("-JAI:"N"0 &T97)P
M$"*M= S!'2<20B(ZHG@)4"86XK</#];9ODOL"HI^PQH.6!D$)+WV3%A$P#BJ
M12 5@HH8O]C,LVQ+^)O@L81X0@@T#X#4TH>($V2R%RH5Z).M!8FV8G[<'T]7
MRR1/;2>7;8FS.0DP5\U(1GD0; "F3!:*,L0>T/'T+ZN_(AWEN/MOV))CF3QV
ML=^L6 IDG[*J7$'085%S8)$$@0+LRZ3AAJ%2BI361W:JAEE+<XQR5P!8;>FN
M;Q0&T>DV1ZTO?Z.O/0WYE[OH49@BP L)=IGKH=]FTAS^ZYH@$.@PUCHI*:5(
M:WV\D'"8LM;]BX"UMT7 NF<1L YQ$; >N@A8>UL$Z-VJ%"%B7+I=I<D: \D)
M.]6NH>BP;/)AD0:%"NP/'#.J$'2(<9W1LDAQ)M/S\TVQ_ROQP=)*0.<LIV67
MS2JII4T4!"-=SEII+572N9H82;5K+K9QDI-8F;E***91@M,J/:+MBGA_B#-:
M!IJOP.G1A\'0,),MG%28SF58!1Y27;J^E*X>P/B5I.G/E+W2!<$9HR16UU)L
M=XJZ]6Z?F.FQW7QH!A '@=,0A\"C,S)H_"2CD XKKX1Y(>D;2[<TQ[QXEYS;
M1B9 YY8<P&:3&$,4$"EV9P AE1@IM9\7M%7VB&J1I7YW"&P@)'?\NG:G:>.M
M;:LV(&8Z#4+O<)<Y/PYK8Q7EZ17+G,C?BTA>R!><X](;V%Y([OJERB[3YMN4
M-FU "'4:!-^?K&)DJABLF?*6,H;/Q%)KS3J>$C=4[A/'M"RV<\=4DH#PL/GJ
MR"##D=9Z86&QP6GZ>9LEE&3P1&2HW+)@M=ADH2$)B 6;+X"%0HJTU@L+EQO"
MUV)Z^XFSU_RQS,\*M@U0NV6CTW*3$:LT(%:Z_ ',Z!"D8G1*73_P[ X)Q566
M1;BE%JEC;$"S!C,M74C 0.9:M*0DDM=;;EB.E@Q]S0C*'PFZ+'^&KIX)7M7C
MZY=&HDB^$*%6Y33&W(90E]CYKXZ AEN_/=)2!@%2KSWX=TBJ"*1#'%-S*QCF
M]?.XPL0\)QOP;8?^$%<$#36O.>K3!T'30),F4T58\^2Z"$0RTF<VHWIR>WB)
MUQ Y7AE;#!H+XYHB"$9 6]"RN/Y; 7YRYVU7:1)=I0S#5UD:&L<9\]KVC&1Y
M!T% !+1=02GR"B$JE%[Z_S.F3WS[G$?[.\XB0N135EDU6O5=?QL8[9:9-S6I
M2=.@T( X>XM?@,!#%:A6QX?:C.7S8IY\:%QF<V/1T^(1BP-XN\TS.8,*8_!5
M\,X@Q[<7!C3 N,G0$1$0>@-L0C<<BDA4A'Y *AC5HCV=GV6'+( D_KR_)P^$
MR_<.EF27?Q8[>NHXPQ@0Z_KL;7!SS).YWL @('RK6^A4+T/U"M!*/B-65H%^
MDY6@HA;;[Y?7-UV+3V*SWB3^6N&,B"W_!5!+ P04    "  *.-56&KA>0E@'
M  #55P  %0   '9S=&TM,C R,S V,35?<')E+GAM;,V<75/;.!2&[W=F_X,W
M>QU"PK9;*&P'4M+)E )+:+N[-QW%5A(-LI219)+\^Y7L.,V')1]N?. "@O/J
MXWV.+?O8DL\_+%,>/5.EF107K>[1<2NB(I8)$].+UM=1^W+4'PY;D39$)(1+
M02]:0K8^_/7K+Y'].?^MW8X&C/+D+/HHX_903.3[Z):D]"SZ1 55Q$CU/OI&
M>.:VR 'C5$5]F<XY-=1^431\%KTYZKX;1^TVH-YO5"12?7T8;NJ=&3/79YW.
M8K$X$O*9+*1ZTD>Q3&$5C@PQF=[4=KP\7O\4Q<\Y$T]G[M>8:!I97D*?+36[
M:+EVU\TN3HZDFG9ZQ\?=SC]?;D;QC*:DS83C%M-66<K54E6N>WIZVLF_+:4'
MRN58\;*-DT[9G4W-]EL6T&_U1+,SG7?O1L;$Y&&O;2;R*MQ_[5+6=IO:W5[[
MI'NTU$FKA)\35)+3!SJ)W%\;O4VK=N<CVM#4!:SCONSTI=UF>YH7FRDZN6@]
M:Y/:VGLGQV^[;US=O^^(S&IN=TS-W'[5BCH[[<X5U528W.J-W;!3A"Z-W9UH
M4E;DVH?VS##CQ.N=I1NUW9Z5I;8M^[%0KCM2=H7+>*=U[B(@]ZR6>W/.6=/X
M:"J?.PEEEG>OYSXX#KV<@?WG1][0Y5@;16)3UL3)F/*\_A]6LR?I--"KDL2C
MK;&Z4[N*_3YM!^U2Q9%4"566=5D74?%.J YWS+6B,R?*5M2.9XQOHCQ1,O71
M69.0GHYN@[)--$/STK:?N#X,.)E6X]R3 'EV,8!6NL$B^I'J6+&YXU(#=D<)
MY-M#Y5OAK6',Y;'S0*?,]==UQ9UNJ=L8'A<\18#@3S!'BJ!;I A<"I$1_D#G
M4M6 WU4">?^!R;O*&Q+FOS.B#%5\!2%]( ;"?H,)V^,0B?>C(D(SQP<"_% -
M)/X6]<+#XQ$)^6A&.7<I'!&@O;Q*#\3^)R9VO\]7 /[ZV9W?[:D%SGZK"!#_
MN]>"_\ M4@3NJ6(RL:=T!6!_( 92/\6D[G&(ROM:)%#:&RDX_\&'O6</"?6
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MZ;QSX.O&;G#OIRV^<;_<.UCMEO\!4$L! A0#%     @ "CC55DU?8^RY&
MC($  !(              ( !     '1M,C,Q.#,Q-60S7SAK+FAT;5!+ 0(4
M Q0    (  HXU58+J7?MB*,  /?@ P 5              "  >D8  !T;3(S
M,3@S,35D,U]E>#$M,2YH=&U02P$"% ,4    "  *.-56SH(KP,,R   Y( $
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M,C R,S V,34N>'-D4$L! A0#%     @ "CC55@RN\&S^"@  @(8  !4
M         ( !@ $! '9S=&TM,C R,S V,35?;&%B+GAM;%!+ 0(4 Q0    (
M  HXU58:N%Y"6 <  -57   5              "  ;$, 0!V<W1M+3(P,C,P
A-C$U7W!R92YX;6Q02P4&      @ "  2 @  /!0!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
